Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfx
|
ENSMUSG00000079509.4 | zinc finger protein X-linked |
Zfp711
|
ENSMUSG00000025529.8 | zinc finger protein 711 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_112600837_112601843 | Zfp711 | 814 | 0.677107 | -0.90 | 3.0e-20 | Click! |
chrX_112600479_112600830 | Zfp711 | 128 | 0.970033 | -0.88 | 4.0e-19 | Click! |
chrX_94121229_94121390 | Zfx | 1591 | 0.405442 | 0.28 | 3.8e-02 | Click! |
chrX_94103042_94103193 | Zfx | 19783 | 0.174374 | 0.18 | 2.0e-01 | Click! |
chrX_94123058_94123280 | Zfx | 37 | 0.979060 | 0.17 | 2.1e-01 | Click! |
chrX_94152407_94152558 | Zfx | 28780 | 0.152373 | 0.10 | 4.5e-01 | Click! |
chrX_94123286_94123463 | Zfx | 1 | 0.980231 | -0.09 | 5.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_174329445_174331091 | 89.52 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr8_124948019_124949972 | 81.23 |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
329 |
0.85 |
chr10_127508848_127510720 | 63.60 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr14_115040506_115042372 | 62.99 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr11_60104775_60106860 | 62.47 |
Rai1 |
retinoic acid induced 1 |
640 |
0.67 |
chr17_34898151_34899707 | 61.75 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr13_55210517_55212032 | 61.22 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
267 |
0.89 |
chr5_137530580_137532081 | 59.39 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr11_102316544_102317735 | 57.44 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
148 |
0.92 |
chr15_79690079_79691459 | 55.27 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr4_140701770_140702866 | 54.08 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr8_90907824_90909226 | 51.67 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
89 |
0.52 |
chr11_100938783_100940230 | 50.18 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr5_143731658_143732384 | 49.45 |
Usp42 |
ubiquitin specific peptidase 42 |
259 |
0.91 |
chr2_174347204_174348264 | 47.11 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chrY_90771840_90772811 | 47.05 |
Gm47283 |
predicted gene, 47283 |
12413 |
0.17 |
chr17_47923769_47925323 | 44.91 |
Foxp4 |
forkhead box P4 |
70 |
0.96 |
chr14_25606696_25608421 | 44.58 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
201 |
0.95 |
chr19_41482494_41483686 | 43.36 |
Lcor |
ligand dependent nuclear receptor corepressor |
61 |
0.98 |
chr13_43480925_43481874 | 43.03 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr4_138216258_138217700 | 42.79 |
Hp1bp3 |
heterochromatin protein 1, binding protein 3 |
148 |
0.91 |
chr10_80576603_80578409 | 42.56 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr9_65826224_65827697 | 42.48 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr9_63757305_63758776 | 41.81 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr6_72898945_72900607 | 40.92 |
Kcmf1 |
potassium channel modulatory factor 1 |
73 |
0.97 |
chr9_109094576_109096217 | 40.42 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr16_94570319_94571250 | 40.16 |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
80 |
0.97 |
chr15_81585272_81586453 | 39.61 |
Gm23880 |
predicted gene, 23880 |
271 |
0.52 |
chr5_122501856_122502977 | 38.95 |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
191 |
0.88 |
chr11_88068171_88069196 | 38.58 |
Vezf1 |
vascular endothelial zinc finger 1 |
404 |
0.76 |
chrX_169997850_169998483 | 38.53 |
Gm15247 |
predicted gene 15247 |
11227 |
0.14 |
chr11_11684707_11686418 | 38.50 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr11_12036502_12038049 | 38.16 |
Grb10 |
growth factor receptor bound protein 10 |
126 |
0.97 |
chr5_115436438_115437458 | 38.16 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr4_46450476_46451941 | 37.26 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
306 |
0.86 |
chr4_131920531_131921931 | 36.74 |
Tmem200b |
transmembrane protein 200B |
31 |
0.78 |
chr11_97440036_97440725 | 36.58 |
Arhgap23 |
Rho GTPase activating protein 23 |
4095 |
0.19 |
chr19_46038782_46039575 | 35.82 |
Ldb1 |
LIM domain binding 1 |
303 |
0.84 |
chr9_61370339_61371660 | 35.79 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr6_72097140_72098281 | 35.72 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
47 |
0.96 |
chr15_100599610_100600576 | 35.66 |
Pou6f1 |
POU domain, class 6, transcription factor 1 |
109 |
0.48 |
chr2_170130477_170131578 | 35.45 |
Zfp217 |
zinc finger protein 217 |
193 |
0.97 |
chr13_58006958_58007325 | 35.33 |
Mir874 |
microRNA 874 |
16059 |
0.21 |
chr15_98608664_98610204 | 35.19 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr9_106367425_106368835 | 35.07 |
Dusp7 |
dual specificity phosphatase 7 |
502 |
0.7 |
chr8_123982265_123983435 | 34.52 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
272 |
0.84 |
chr14_55824498_55825973 | 34.51 |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
198 |
0.87 |
chr1_33630885_33631502 | 34.42 |
Prim2 |
DNA primase, p58 subunit |
7869 |
0.14 |
chr9_21615608_21616677 | 34.35 |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
27 |
0.95 |
chr12_51828795_51830087 | 34.30 |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
95 |
0.97 |
chr9_110116697_110117249 | 34.13 |
Dhx30 |
DEAH (Asp-Glu-Ala-His) box polypeptide 30 |
114 |
0.9 |
chr2_29619511_29620559 | 33.85 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
125 |
0.97 |
chr7_141508026_141508712 | 33.22 |
Gm45416 |
predicted gene 45416 |
10234 |
0.08 |
chr15_96286955_96287696 | 33.11 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
193 |
0.94 |
chr12_51691136_51692207 | 32.81 |
Strn3 |
striatin, calmodulin binding protein 3 |
216 |
0.81 |
chr11_87986817_87988025 | 32.61 |
Dynll2 |
dynein light chain LC8-type 2 |
65 |
0.96 |
chr13_98925848_98926492 | 32.42 |
Tnpo1 |
transportin 1 |
184 |
0.92 |
chr4_131873537_131874159 | 32.24 |
Srsf4 |
serine and arginine-rich splicing factor 4 |
32 |
0.96 |
chr2_25982690_25983958 | 31.85 |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
42 |
0.97 |
chr4_129513695_129514851 | 31.77 |
Marcksl1 |
MARCKS-like 1 |
692 |
0.46 |
chr1_46852832_46854284 | 31.75 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
488 |
0.78 |
chr2_165884402_165885933 | 31.55 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr8_79638728_79640227 | 31.50 |
Otud4 |
OTU domain containing 4 |
141 |
0.96 |
chr8_122551277_122551909 | 31.24 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
264 |
0.83 |
chr1_63113503_63114557 | 31.13 |
Ino80dos |
INO80 complex subunit D, opposite strand |
66 |
0.7 |
chr5_109557850_109558797 | 31.04 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr8_84687190_84687730 | 30.95 |
Nacc1 |
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing |
131 |
0.89 |
chr10_127739271_127740118 | 30.71 |
Zbtb39 |
zinc finger and BTB domain containing 39 |
156 |
0.89 |
chr5_96162084_96163134 | 30.46 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chr9_57644752_57646108 | 30.40 |
Csk |
c-src tyrosine kinase |
187 |
0.91 |
chr8_70698268_70700333 | 30.31 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr15_89180069_89181444 | 30.31 |
Plxnb2 |
plexin B2 |
32 |
0.95 |
chrX_142680720_142682167 | 30.25 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr2_69897352_69898558 | 30.21 |
Ubr3 |
ubiquitin protein ligase E3 component n-recognin 3 |
652 |
0.6 |
chr15_75747756_75749006 | 30.08 |
Mafa |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
153 |
0.93 |
chr2_144010017_144011636 | 30.02 |
Rrbp1 |
ribosome binding protein 1 |
437 |
0.82 |
chr3_58415944_58417384 | 29.96 |
Tsc22d2 |
TSC22 domain family, member 2 |
786 |
0.64 |
chr7_25686729_25687529 | 29.64 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr4_45530265_45531442 | 29.34 |
Shb |
src homology 2 domain-containing transforming protein B |
523 |
0.73 |
chr4_33923766_33925291 | 29.26 |
Cnr1 |
cannabinoid receptor 1 (brain) |
65 |
0.98 |
chr10_80150235_80151164 | 28.93 |
Midn |
midnolin |
242 |
0.82 |
chr11_5740506_5741309 | 28.92 |
Urgcp |
upregulator of cell proliferation |
239 |
0.89 |
chr5_124862398_124863348 | 28.87 |
Zfp664 |
zinc finger protein 664 |
109 |
0.84 |
chr12_59131240_59132031 | 28.78 |
Mia2 |
MIA SH3 domain ER export factor 2 |
133 |
0.94 |
chr13_91460972_91461704 | 28.73 |
Ssbp2 |
single-stranded DNA binding protein 2 |
157 |
0.97 |
chr3_51340298_51341882 | 28.58 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr9_70678675_70679795 | 27.99 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
219 |
0.93 |
chr3_35932298_35933364 | 27.97 |
Dcun1d1 |
DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) |
5 |
0.73 |
chr15_82340990_82341511 | 27.88 |
Pheta2 |
PH domain containing endocytic trafficking adaptor 2 |
71 |
0.71 |
chr15_103014087_103015222 | 27.73 |
Mir615 |
microRNA 615 |
256 |
0.74 |
chr1_134559997_134561478 | 27.57 |
Kdm5b |
lysine (K)-specific demethylase 5B |
530 |
0.69 |
chr3_95314674_95315950 | 27.51 |
Cers2 |
ceramide synthase 2 |
45 |
0.67 |
chr6_124919273_124920636 | 27.48 |
Ptms |
parathymosin |
149 |
0.88 |
chr17_29436902_29437574 | 27.42 |
Gm36486 |
predicted gene, 36486 |
172 |
0.91 |
chr11_75651168_75652336 | 27.39 |
Myo1c |
myosin IC |
242 |
0.88 |
chr11_106084123_106085101 | 27.34 |
Map3k3 |
mitogen-activated protein kinase kinase kinase 3 |
1 |
0.96 |
chr9_61373312_61374646 | 27.19 |
Tle3 |
transducin-like enhancer of split 3 |
307 |
0.87 |
chr4_154025644_154026533 | 27.09 |
Smim1 |
small integral membrane protein 1 |
51 |
0.95 |
chr5_137349031_137350198 | 27.07 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr14_14354416_14355184 | 27.02 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr13_34344501_34346084 | 26.74 |
Slc22a23 |
solute carrier family 22, member 23 |
110 |
0.97 |
chr16_32643757_32644967 | 26.74 |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
71 |
0.96 |
chr15_85669900_85671551 | 26.63 |
Lncppara |
long noncoding RNA near Ppara |
17109 |
0.13 |
chr8_84197696_84198961 | 26.61 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr13_9763721_9765322 | 26.55 |
Zmynd11 |
zinc finger, MYND domain containing 11 |
33 |
0.97 |
chr6_125095392_125097556 | 26.54 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr8_120486990_120488549 | 26.54 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr17_28800512_28801462 | 26.50 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
103 |
0.88 |
chr11_117968531_117970182 | 26.49 |
Socs3 |
suppressor of cytokine signaling 3 |
95 |
0.96 |
chr17_46555466_46556535 | 26.48 |
Srf |
serum response factor |
175 |
0.9 |
chr2_26139656_26141133 | 26.47 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr13_63564531_63566515 | 26.42 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr16_91043770_91045002 | 26.06 |
Paxbp1 |
PAX3 and PAX7 binding protein 1 |
32 |
0.78 |
chr11_87763473_87764852 | 25.84 |
Tspoap1 |
TSPO associated protein 1 |
569 |
0.56 |
chr1_74001484_74001792 | 25.71 |
Tns1 |
tensin 1 |
71 |
0.98 |
chr4_45341633_45342861 | 25.65 |
Dcaf10 |
DDB1 and CUL4 associated factor 10 |
65 |
0.87 |
chr1_59762633_59764016 | 25.61 |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
76 |
0.96 |
chrX_168673064_168674616 | 25.59 |
Msl3 |
MSL complex subunit 3 |
58 |
0.98 |
chr11_74896307_74898160 | 25.55 |
Sgsm2 |
small G protein signaling modulator 2 |
173 |
0.84 |
chr10_128525093_128526268 | 25.52 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr17_24208511_24209934 | 25.44 |
Ntn3 |
netrin 3 |
177 |
0.67 |
chr2_156720289_156721547 | 25.39 |
4930405A21Rik |
RIKEN cDNA 4930405A21 gene |
9 |
0.6 |
chr7_16046417_16047443 | 25.32 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
991 |
0.44 |
chr1_86525613_86527056 | 25.23 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr11_3202493_3203344 | 25.22 |
Eif4enif1 |
eukaryotic translation initiation factor 4E nuclear import factor 1 |
77 |
0.95 |
chr3_87905763_87907208 | 25.19 |
Hdgf |
heparin binding growth factor |
164 |
0.9 |
chr11_102347634_102348245 | 25.11 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
12629 |
0.1 |
chr11_85843373_85844045 | 25.06 |
Gm11444 |
predicted gene 11444 |
6624 |
0.13 |
chr13_41605449_41606727 | 25.06 |
Tmem170b |
transmembrane protein 170B |
128 |
0.96 |
chr2_104493355_104494675 | 25.03 |
Hipk3 |
homeodomain interacting protein kinase 3 |
61 |
0.97 |
chr15_102470670_102471447 | 24.96 |
Pcbp2 |
poly(rC) binding protein 2 |
10 |
0.95 |
chr4_46452009_46452739 | 24.91 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
1472 |
0.31 |
chrX_51204673_51205680 | 24.78 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr4_128727717_128728042 | 24.59 |
Phc2 |
polyhomeotic 2 |
54 |
0.97 |
chr17_3114762_3115867 | 24.51 |
Scaf8 |
SR-related CTD-associated factor 8 |
65 |
0.87 |
chr11_77607040_77608322 | 24.51 |
Taok1 |
TAO kinase 1 |
134 |
0.94 |
chr8_83997571_83998713 | 24.49 |
Samd1 |
sterile alpha motif domain containing 1 |
282 |
0.75 |
chr10_81544563_81545953 | 24.25 |
Gna11 |
guanine nucleotide binding protein, alpha 11 |
68 |
0.92 |
chr19_46396648_46397747 | 24.13 |
Sufu |
SUFU negative regulator of hedgehog signaling |
171 |
0.89 |
chr7_126271797_126273090 | 24.11 |
Sbk1 |
SH3-binding kinase 1 |
176 |
0.92 |
chr7_44985781_44987176 | 24.09 |
Prmt1 |
protein arginine N-methyltransferase 1 |
14 |
0.83 |
chr13_17803284_17804137 | 24.05 |
Cdk13 |
cyclin-dependent kinase 13 |
242 |
0.89 |
chr11_120597854_120599056 | 24.03 |
Anapc11 |
anaphase promoting complex subunit 11 |
15 |
0.55 |
chr11_60114297_60115906 | 24.01 |
4930412M03Rik |
RIKEN cDNA 4930412M03 gene |
129 |
0.95 |
chr8_108714518_108715488 | 23.96 |
Zfhx3 |
zinc finger homeobox 3 |
359 |
0.9 |
chr11_103132227_103133103 | 23.93 |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
236 |
0.88 |
chr10_53379064_53380347 | 23.91 |
Cep85l |
centrosomal protein 85-like |
242 |
0.49 |
chr17_15375662_15377138 | 23.88 |
Dll1 |
delta like canonical Notch ligand 1 |
424 |
0.8 |
chr11_19924323_19926342 | 23.85 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr11_117114876_117115708 | 23.82 |
Sec14l1 |
SEC14-like lipid binding 1 |
40 |
0.96 |
chr4_152086414_152087408 | 23.66 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
53 |
0.96 |
chr17_28176553_28177770 | 23.63 |
Zfp523 |
zinc finger protein 523 |
2 |
0.89 |
chr12_80790259_80791211 | 23.58 |
Susd6 |
sushi domain containing 6 |
176 |
0.72 |
chr6_83456116_83457458 | 23.45 |
Tet3 |
tet methylcytosine dioxygenase 3 |
395 |
0.77 |
chr6_4902832_4903901 | 23.42 |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
7 |
0.97 |
chr18_35848127_35849279 | 23.36 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chr2_60124621_60125204 | 23.27 |
Gm13620 |
predicted gene 13620 |
184 |
0.84 |
chr8_104395019_104396337 | 23.26 |
Cmtm4 |
CKLF-like MARVEL transmembrane domain containing 4 |
129 |
0.93 |
chr16_30063252_30064537 | 23.21 |
Hes1 |
hes family bHLH transcription factor 1 |
490 |
0.76 |
chr2_44926591_44927289 | 23.18 |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
209 |
0.96 |
chr19_29251015_29252343 | 23.14 |
Jak2 |
Janus kinase 2 |
149 |
0.96 |
chr11_105181488_105182080 | 23.02 |
Tlk2 |
tousled-like kinase 2 (Arabidopsis) |
9 |
0.84 |
chr8_87961261_87962490 | 22.97 |
Zfp423 |
zinc finger protein 423 |
2280 |
0.39 |
chr11_3289074_3290615 | 22.93 |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
149 |
0.93 |
chr12_111039101_111039789 | 22.93 |
Rcor1 |
REST corepressor 1 |
94 |
0.95 |
chr5_107986404_107987625 | 22.87 |
Dipk1a |
divergent protein kinase domain 1A |
19 |
0.97 |
chr3_108591016_108592049 | 22.85 |
Wdr47 |
WD repeat domain 47 |
143 |
0.91 |
chr9_44334179_44335476 | 22.74 |
H2ax |
H2A.X variant histone |
133 |
0.57 |
chr11_114066488_114067724 | 22.68 |
Sdk2 |
sidekick cell adhesion molecule 2 |
60 |
0.98 |
chr18_82474598_82476191 | 22.62 |
Mbp |
myelin basic protein |
24 |
0.98 |
chr5_124445674_124446218 | 22.61 |
Kmt5a |
lysine methyltransferase 5A |
162 |
0.91 |
chr11_105589210_105590456 | 22.56 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
153 |
0.96 |
chr11_98741567_98742727 | 22.52 |
Thra |
thyroid hormone receptor alpha |
11 |
0.95 |
chr6_145250129_145251086 | 22.46 |
Gm15706 |
predicted gene 15706 |
78 |
0.81 |
chr9_35116070_35117303 | 22.32 |
4930581F22Rik |
RIKEN cDNA 4930581F22 gene |
42 |
0.69 |
chr14_62760761_62761843 | 22.27 |
Ints6 |
integrator complex subunit 6 |
133 |
0.95 |
chr2_106692893_106694599 | 22.25 |
Mpped2 |
metallophosphoesterase domain containing 2 |
477 |
0.85 |
chr7_19004190_19004941 | 22.22 |
Irf2bp1 |
interferon regulatory factor 2 binding protein 1 |
521 |
0.54 |
chr1_30872861_30873576 | 22.19 |
Phf3 |
PHD finger protein 3 |
34 |
0.97 |
chr15_76816855_76818442 | 22.13 |
Arhgap39 |
Rho GTPase activating protein 39 |
322 |
0.82 |
chr5_115010914_115011989 | 22.04 |
Sppl3 |
signal peptide peptidase 3 |
46 |
0.95 |
chr5_22344110_22345571 | 21.97 |
Reln |
reelin |
138 |
0.95 |
chr2_154569188_154570416 | 21.96 |
E2f1 |
E2F transcription factor 1 |
82 |
0.95 |
chr12_76709620_76710348 | 21.96 |
Sptb |
spectrin beta, erythrocytic |
39 |
0.98 |
chr8_70609185_70610414 | 21.95 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr11_74837693_74838808 | 21.94 |
Mnt |
max binding protein |
782 |
0.52 |
chr5_135393978_135394601 | 21.91 |
Pom121 |
nuclear pore membrane protein 121 |
257 |
0.87 |
chr2_75703696_75705127 | 21.83 |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
78 |
0.81 |
chr9_50856310_50857724 | 21.83 |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
38 |
0.97 |
chr19_53310330_53311359 | 21.81 |
Mxi1 |
MAX interactor 1, dimerization protein |
326 |
0.85 |
chr2_60880792_60881813 | 21.76 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
136 |
0.98 |
chr2_128966994_128968230 | 21.72 |
Gm10762 |
predicted gene 10762 |
113 |
0.62 |
chr19_57360894_57361673 | 21.68 |
Fam160b1 |
family with sequence similarity 160, member B1 |
253 |
0.71 |
chr7_142658735_142659435 | 21.54 |
Igf2 |
insulin-like growth factor 2 |
404 |
0.55 |
chr5_121545189_121545856 | 21.49 |
Adam1a |
a disintegrin and metallopeptidase domain 1a |
40 |
0.44 |
chr6_97204968_97206158 | 21.46 |
Uba3 |
ubiquitin-like modifier activating enzyme 3 |
2 |
0.97 |
chr7_16400439_16400945 | 21.46 |
Zc3h4 |
zinc finger CCCH-type containing 4 |
218 |
0.87 |
chr5_124091870_124092203 | 21.45 |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
1774 |
0.21 |
chr5_36713069_36713508 | 21.43 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
17264 |
0.12 |
chr4_126148288_126148853 | 21.41 |
Eva1b |
eva-1 homolog B (C. elegans) |
38 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
32.7 | 98.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
30.1 | 120.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
26.7 | 53.4 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
24.5 | 73.6 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
21.3 | 85.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
20.3 | 60.9 | GO:0036166 | phenotypic switching(GO:0036166) |
19.5 | 39.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
19.3 | 19.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
19.0 | 76.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
18.8 | 56.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
18.4 | 55.2 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
18.0 | 53.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
17.7 | 53.1 | GO:0002432 | granuloma formation(GO:0002432) |
16.9 | 16.9 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
15.6 | 93.4 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
15.3 | 45.9 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
15.1 | 60.5 | GO:0007296 | vitellogenesis(GO:0007296) |
15.1 | 45.2 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
15.0 | 45.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
14.9 | 59.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
14.7 | 44.0 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
14.5 | 58.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
14.4 | 28.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
14.2 | 42.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
14.1 | 42.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
14.1 | 42.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
13.9 | 41.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
13.9 | 41.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
13.6 | 67.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
13.5 | 40.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
13.5 | 53.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
13.0 | 103.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
12.6 | 63.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
12.6 | 25.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
12.5 | 50.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
12.4 | 86.6 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
12.2 | 49.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
12.1 | 36.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
12.1 | 12.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
11.9 | 59.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
11.8 | 47.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
11.7 | 46.9 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
11.7 | 35.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
11.6 | 46.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
11.6 | 58.1 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
11.5 | 115.4 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
11.5 | 92.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
11.5 | 46.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
11.4 | 11.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
11.3 | 56.5 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
11.2 | 11.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
11.2 | 22.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
11.2 | 11.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
11.1 | 33.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
11.0 | 11.0 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
11.0 | 33.0 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
11.0 | 32.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
10.9 | 10.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
10.8 | 10.8 | GO:0070384 | Harderian gland development(GO:0070384) |
10.6 | 21.1 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
10.5 | 21.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
10.5 | 21.0 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
10.4 | 31.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
10.4 | 31.2 | GO:0045472 | response to ether(GO:0045472) |
10.2 | 30.6 | GO:0042938 | dipeptide transport(GO:0042938) |
10.2 | 30.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
10.2 | 30.6 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
10.1 | 30.3 | GO:0042117 | monocyte activation(GO:0042117) |
10.1 | 30.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
10.0 | 40.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
10.0 | 29.9 | GO:0036394 | amylase secretion(GO:0036394) |
9.9 | 39.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
9.9 | 39.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
9.8 | 58.9 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
9.7 | 77.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
9.7 | 9.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
9.6 | 48.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
9.6 | 19.3 | GO:1902075 | cellular response to salt(GO:1902075) |
9.6 | 9.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
9.6 | 28.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
9.5 | 47.4 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
9.5 | 123.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
9.5 | 18.9 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
9.4 | 28.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
9.4 | 9.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
9.4 | 131.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
9.4 | 46.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
9.3 | 9.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
9.3 | 27.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
9.3 | 27.9 | GO:0000087 | mitotic M phase(GO:0000087) |
9.3 | 27.8 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
9.3 | 27.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
9.3 | 9.3 | GO:0043622 | cortical microtubule organization(GO:0043622) |
9.3 | 92.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
9.2 | 27.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
9.2 | 18.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
9.2 | 9.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
9.1 | 18.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
9.1 | 18.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
9.0 | 9.0 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
8.8 | 8.8 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
8.8 | 17.5 | GO:0035973 | aggrephagy(GO:0035973) |
8.7 | 8.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
8.7 | 26.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
8.6 | 34.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
8.6 | 34.5 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
8.6 | 42.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
8.5 | 51.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
8.5 | 68.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
8.5 | 59.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
8.5 | 25.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
8.5 | 152.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
8.5 | 16.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
8.4 | 33.8 | GO:0060596 | mammary placode formation(GO:0060596) |
8.4 | 42.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
8.4 | 50.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
8.4 | 25.2 | GO:0007525 | somatic muscle development(GO:0007525) |
8.4 | 16.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
8.4 | 33.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
8.3 | 16.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
8.3 | 16.5 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
8.2 | 24.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
8.2 | 16.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
8.2 | 8.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
8.1 | 32.5 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
8.1 | 32.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
8.0 | 32.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
8.0 | 15.9 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
8.0 | 63.6 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
7.9 | 7.9 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
7.9 | 39.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
7.8 | 23.5 | GO:0061010 | gall bladder development(GO:0061010) |
7.8 | 23.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
7.8 | 31.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
7.8 | 23.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
7.7 | 30.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
7.7 | 23.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
7.7 | 46.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
7.7 | 23.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
7.7 | 46.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
7.7 | 15.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
7.6 | 30.5 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
7.6 | 7.6 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
7.6 | 45.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
7.6 | 68.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
7.6 | 15.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
7.4 | 22.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
7.4 | 37.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
7.4 | 7.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
7.4 | 29.6 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
7.4 | 7.4 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
7.4 | 22.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
7.3 | 14.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
7.3 | 22.0 | GO:0003032 | detection of oxygen(GO:0003032) |
7.3 | 36.4 | GO:0070627 | ferrous iron import(GO:0070627) |
7.2 | 7.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
7.2 | 28.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
7.2 | 21.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
7.2 | 43.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
7.2 | 21.6 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
7.2 | 28.8 | GO:0070836 | caveola assembly(GO:0070836) |
7.2 | 115.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
7.2 | 14.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
7.2 | 35.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
7.1 | 21.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
7.1 | 28.2 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
7.0 | 21.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
7.0 | 35.2 | GO:0050779 | RNA destabilization(GO:0050779) |
7.0 | 21.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
7.0 | 14.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
7.0 | 20.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
7.0 | 27.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
6.9 | 34.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
6.9 | 27.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
6.9 | 6.9 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
6.9 | 6.9 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
6.9 | 20.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
6.9 | 20.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
6.9 | 27.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
6.8 | 34.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
6.8 | 54.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
6.8 | 27.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
6.8 | 6.8 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
6.8 | 27.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
6.8 | 6.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
6.7 | 13.5 | GO:0030575 | nuclear body organization(GO:0030575) |
6.7 | 73.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
6.7 | 6.7 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
6.7 | 20.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
6.7 | 13.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
6.7 | 13.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
6.6 | 33.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
6.6 | 6.6 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
6.6 | 19.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
6.6 | 6.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
6.5 | 19.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
6.5 | 19.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
6.5 | 19.5 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
6.5 | 19.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
6.4 | 19.3 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
6.4 | 19.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
6.4 | 38.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
6.4 | 38.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
6.4 | 12.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
6.3 | 82.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
6.3 | 12.5 | GO:0050904 | diapedesis(GO:0050904) |
6.3 | 18.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
6.3 | 37.5 | GO:0001842 | neural fold formation(GO:0001842) |
6.2 | 18.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
6.2 | 6.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
6.2 | 6.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
6.2 | 61.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
6.2 | 18.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
6.1 | 12.3 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
6.1 | 30.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
6.1 | 55.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
6.1 | 12.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
6.1 | 6.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
6.1 | 73.4 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
6.1 | 55.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
6.1 | 36.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
6.1 | 24.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
6.1 | 18.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
6.1 | 12.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
6.1 | 18.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
6.0 | 18.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
6.0 | 24.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
6.0 | 18.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
6.0 | 18.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
6.0 | 24.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
6.0 | 66.0 | GO:0009299 | mRNA transcription(GO:0009299) |
6.0 | 12.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
6.0 | 47.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
6.0 | 17.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
6.0 | 47.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
6.0 | 17.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
6.0 | 35.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
6.0 | 17.9 | GO:0044794 | positive regulation by host of viral process(GO:0044794) positive regulation by host of viral genome replication(GO:0044829) |
6.0 | 29.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
6.0 | 53.6 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
5.9 | 11.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
5.9 | 23.7 | GO:0015886 | heme transport(GO:0015886) |
5.9 | 29.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
5.9 | 11.8 | GO:0035789 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
5.9 | 17.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
5.9 | 17.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
5.9 | 41.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
5.9 | 41.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
5.9 | 5.9 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
5.8 | 134.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
5.8 | 5.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
5.8 | 5.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
5.8 | 17.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
5.8 | 29.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
5.8 | 11.6 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
5.8 | 40.6 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
5.8 | 28.9 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
5.8 | 46.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
5.8 | 23.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
5.7 | 63.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
5.7 | 28.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
5.7 | 5.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
5.7 | 11.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
5.7 | 17.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
5.7 | 11.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
5.7 | 5.7 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
5.7 | 22.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
5.7 | 45.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
5.7 | 17.0 | GO:0034214 | protein hexamerization(GO:0034214) |
5.7 | 5.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
5.7 | 5.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
5.7 | 5.7 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
5.7 | 84.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
5.7 | 17.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
5.7 | 11.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
5.6 | 11.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
5.6 | 45.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
5.6 | 5.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
5.6 | 11.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
5.6 | 22.4 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
5.6 | 16.7 | GO:0046104 | thymidine metabolic process(GO:0046104) |
5.6 | 44.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
5.6 | 44.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
5.6 | 89.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
5.6 | 16.7 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
5.6 | 16.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
5.6 | 38.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
5.5 | 11.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
5.5 | 5.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
5.5 | 16.5 | GO:0048102 | autophagic cell death(GO:0048102) |
5.5 | 49.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
5.5 | 21.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
5.4 | 21.8 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
5.4 | 16.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
5.4 | 5.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
5.4 | 27.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
5.4 | 10.8 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
5.4 | 21.6 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
5.4 | 10.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
5.4 | 26.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
5.4 | 5.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
5.3 | 26.7 | GO:0072553 | terminal button organization(GO:0072553) |
5.3 | 16.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
5.3 | 21.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
5.3 | 10.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
5.3 | 15.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
5.3 | 58.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
5.3 | 26.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
5.3 | 100.2 | GO:0006301 | postreplication repair(GO:0006301) |
5.3 | 36.9 | GO:0046060 | dATP metabolic process(GO:0046060) |
5.3 | 21.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
5.2 | 26.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
5.2 | 26.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
5.2 | 10.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
5.2 | 5.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
5.2 | 10.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
5.2 | 5.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
5.2 | 20.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
5.1 | 20.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
5.1 | 15.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
5.1 | 15.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
5.1 | 41.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
5.1 | 15.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
5.1 | 15.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
5.1 | 86.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
5.1 | 20.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
5.1 | 15.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
5.1 | 15.3 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
5.1 | 10.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
5.1 | 15.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
5.1 | 25.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
5.1 | 15.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
5.1 | 20.2 | GO:0036302 | atrioventricular canal development(GO:0036302) |
5.0 | 45.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
5.0 | 30.2 | GO:0072537 | fibroblast activation(GO:0072537) |
5.0 | 30.2 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
5.0 | 15.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
4.9 | 39.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
4.9 | 19.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
4.9 | 9.9 | GO:0003162 | atrioventricular node development(GO:0003162) |
4.9 | 34.6 | GO:0032782 | bile acid secretion(GO:0032782) |
4.9 | 9.9 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
4.9 | 14.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
4.9 | 14.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
4.9 | 19.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
4.9 | 9.8 | GO:0043379 | memory T cell differentiation(GO:0043379) |
4.9 | 9.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
4.9 | 39.0 | GO:0007097 | nuclear migration(GO:0007097) |
4.9 | 14.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
4.9 | 14.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
4.9 | 24.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
4.9 | 9.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
4.8 | 14.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
4.8 | 24.1 | GO:0097459 | iron ion import into cell(GO:0097459) |
4.8 | 28.9 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
4.8 | 4.8 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
4.8 | 33.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
4.8 | 14.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
4.8 | 80.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
4.7 | 19.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
4.7 | 14.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
4.7 | 23.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
4.7 | 14.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
4.7 | 9.4 | GO:0030578 | PML body organization(GO:0030578) |
4.7 | 42.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
4.7 | 18.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
4.7 | 14.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
4.7 | 23.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
4.7 | 14.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
4.7 | 23.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
4.6 | 4.6 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
4.6 | 32.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
4.6 | 4.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
4.6 | 9.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
4.6 | 9.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
4.6 | 4.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
4.5 | 4.5 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
4.5 | 13.6 | GO:0080009 | mRNA methylation(GO:0080009) |
4.5 | 9.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
4.5 | 13.6 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
4.5 | 4.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
4.5 | 13.6 | GO:0042092 | type 2 immune response(GO:0042092) |
4.5 | 13.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
4.5 | 9.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.5 | 9.0 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
4.5 | 13.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
4.5 | 9.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
4.5 | 18.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
4.5 | 85.3 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
4.5 | 4.5 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
4.5 | 8.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
4.4 | 8.9 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
4.4 | 4.4 | GO:0032570 | response to progesterone(GO:0032570) |
4.4 | 26.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
4.4 | 83.9 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
4.4 | 35.3 | GO:0034063 | stress granule assembly(GO:0034063) |
4.4 | 30.7 | GO:0006547 | histidine metabolic process(GO:0006547) |
4.4 | 30.6 | GO:0010761 | fibroblast migration(GO:0010761) |
4.4 | 4.4 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
4.4 | 13.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
4.4 | 4.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
4.4 | 13.1 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
4.4 | 4.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
4.4 | 21.8 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
4.3 | 4.3 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
4.3 | 13.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
4.3 | 4.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
4.3 | 12.9 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
4.3 | 4.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
4.3 | 38.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
4.3 | 4.3 | GO:0051775 | response to redox state(GO:0051775) |
4.3 | 17.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
4.2 | 8.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
4.2 | 17.0 | GO:0031033 | myosin filament organization(GO:0031033) |
4.2 | 42.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
4.2 | 76.4 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
4.2 | 21.2 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
4.2 | 12.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
4.2 | 16.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
4.2 | 4.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
4.2 | 38.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
4.2 | 8.4 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
4.2 | 8.4 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
4.2 | 42.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
4.2 | 4.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
4.2 | 29.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
4.2 | 12.5 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
4.2 | 20.9 | GO:0015871 | choline transport(GO:0015871) |
4.1 | 24.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
4.1 | 16.6 | GO:0008228 | opsonization(GO:0008228) |
4.1 | 12.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
4.1 | 12.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
4.1 | 29.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
4.1 | 20.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
4.1 | 33.2 | GO:0006907 | pinocytosis(GO:0006907) |
4.1 | 12.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
4.1 | 12.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.1 | 12.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
4.1 | 12.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
4.1 | 8.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
4.1 | 8.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
4.1 | 8.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
4.1 | 24.5 | GO:0048539 | bone marrow development(GO:0048539) |
4.1 | 48.8 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
4.1 | 4.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
4.0 | 8.1 | GO:1903416 | response to glycoside(GO:1903416) |
4.0 | 24.3 | GO:0016266 | O-glycan processing(GO:0016266) |
4.0 | 36.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
4.0 | 12.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
4.0 | 44.4 | GO:0045116 | protein neddylation(GO:0045116) |
4.0 | 36.3 | GO:0043486 | histone exchange(GO:0043486) |
4.0 | 8.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
4.0 | 16.1 | GO:0018101 | protein citrullination(GO:0018101) |
4.0 | 16.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
4.0 | 12.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
4.0 | 20.1 | GO:0006116 | NADH oxidation(GO:0006116) |
4.0 | 8.0 | GO:0070266 | necroptotic process(GO:0070266) |
4.0 | 12.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
4.0 | 44.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
4.0 | 20.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
4.0 | 4.0 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
4.0 | 20.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
4.0 | 12.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
4.0 | 16.0 | GO:0014857 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
4.0 | 4.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
4.0 | 23.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
4.0 | 31.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
3.9 | 7.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
3.9 | 19.7 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of B cell receptor signaling pathway(GO:0050861) |
3.9 | 7.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
3.9 | 7.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
3.9 | 3.9 | GO:0060068 | vagina development(GO:0060068) |
3.9 | 7.9 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.9 | 27.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
3.9 | 23.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
3.9 | 23.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
3.9 | 3.9 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
3.9 | 27.4 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
3.9 | 54.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
3.9 | 11.7 | GO:0072718 | response to cisplatin(GO:0072718) |
3.9 | 7.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.9 | 35.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
3.9 | 3.9 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
3.9 | 3.9 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
3.9 | 19.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
3.9 | 38.7 | GO:0051014 | actin filament severing(GO:0051014) |
3.9 | 11.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
3.9 | 3.9 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
3.9 | 100.2 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
3.9 | 38.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
3.8 | 7.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
3.8 | 15.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.8 | 15.4 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
3.8 | 7.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
3.8 | 11.5 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
3.8 | 11.5 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
3.8 | 7.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
3.8 | 7.6 | GO:0032439 | endosome localization(GO:0032439) |
3.8 | 49.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
3.8 | 15.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
3.8 | 15.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
3.8 | 19.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
3.8 | 45.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
3.8 | 7.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
3.8 | 7.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
3.8 | 7.6 | GO:0055093 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
3.8 | 3.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
3.8 | 18.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
3.8 | 7.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.8 | 48.8 | GO:0016180 | snRNA processing(GO:0016180) |
3.7 | 7.5 | GO:0015793 | glycerol transport(GO:0015793) |
3.7 | 11.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
3.7 | 33.6 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
3.7 | 3.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
3.7 | 3.7 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
3.7 | 7.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
3.7 | 3.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
3.7 | 18.5 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
3.7 | 11.1 | GO:0006573 | valine metabolic process(GO:0006573) |
3.7 | 14.8 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
3.7 | 18.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
3.7 | 18.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
3.7 | 3.7 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
3.7 | 18.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
3.7 | 7.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
3.7 | 7.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
3.7 | 11.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
3.7 | 3.7 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
3.7 | 11.0 | GO:0009838 | abscission(GO:0009838) |
3.7 | 62.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
3.6 | 25.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
3.6 | 10.9 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
3.6 | 18.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
3.6 | 14.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
3.6 | 47.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
3.6 | 7.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
3.6 | 3.6 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
3.6 | 10.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
3.6 | 65.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
3.6 | 14.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
3.6 | 28.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
3.6 | 7.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
3.6 | 7.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
3.6 | 7.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
3.6 | 28.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
3.6 | 14.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
3.6 | 3.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
3.6 | 7.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
3.6 | 10.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
3.6 | 7.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
3.5 | 39.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
3.5 | 14.2 | GO:0045730 | respiratory burst(GO:0045730) |
3.5 | 3.5 | GO:0061724 | lipophagy(GO:0061724) |
3.5 | 21.2 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
3.5 | 3.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
3.5 | 7.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
3.5 | 14.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
3.5 | 21.1 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
3.5 | 7.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
3.5 | 31.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
3.5 | 14.0 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
3.5 | 14.0 | GO:0051031 | tRNA transport(GO:0051031) |
3.5 | 17.5 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
3.5 | 3.5 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
3.5 | 3.5 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
3.5 | 14.0 | GO:0018904 | ether metabolic process(GO:0018904) |
3.5 | 3.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
3.5 | 13.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
3.5 | 6.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
3.5 | 20.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
3.5 | 13.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
3.5 | 51.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
3.4 | 13.8 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
3.4 | 10.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
3.4 | 24.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
3.4 | 27.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
3.4 | 41.2 | GO:0042730 | fibrinolysis(GO:0042730) |
3.4 | 3.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
3.4 | 17.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
3.4 | 40.9 | GO:0035909 | aorta morphogenesis(GO:0035909) |
3.4 | 10.2 | GO:0015744 | succinate transport(GO:0015744) |
3.4 | 13.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
3.4 | 10.2 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
3.4 | 13.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
3.4 | 70.7 | GO:0014823 | response to activity(GO:0014823) |
3.4 | 63.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
3.4 | 16.8 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
3.4 | 20.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
3.4 | 10.1 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
3.4 | 13.4 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
3.3 | 3.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
3.3 | 6.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
3.3 | 26.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
3.3 | 13.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
3.3 | 13.3 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
3.3 | 9.9 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
3.3 | 3.3 | GO:0046618 | xenobiotic transport(GO:0042908) drug export(GO:0046618) |
3.3 | 13.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
3.3 | 9.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
3.3 | 6.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
3.3 | 72.2 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
3.3 | 13.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
3.3 | 9.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
3.3 | 3.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
3.3 | 29.4 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
3.3 | 6.5 | GO:0070831 | basement membrane assembly(GO:0070831) |
3.3 | 26.1 | GO:0051383 | kinetochore organization(GO:0051383) |
3.3 | 29.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
3.3 | 22.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
3.3 | 3.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
3.2 | 22.7 | GO:0015825 | L-serine transport(GO:0015825) |
3.2 | 13.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
3.2 | 3.2 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
3.2 | 19.4 | GO:0048255 | mRNA stabilization(GO:0048255) |
3.2 | 9.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
3.2 | 22.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
3.2 | 6.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.2 | 28.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
3.2 | 35.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
3.2 | 115.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
3.2 | 35.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
3.2 | 9.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
3.2 | 6.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
3.2 | 12.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
3.2 | 19.2 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
3.2 | 9.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
3.2 | 9.5 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
3.2 | 15.9 | GO:0031167 | rRNA methylation(GO:0031167) |
3.2 | 25.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
3.2 | 12.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
3.2 | 6.3 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
3.2 | 9.5 | GO:0019532 | oxalate transport(GO:0019532) |
3.2 | 6.3 | GO:0000819 | sister chromatid segregation(GO:0000819) |
3.2 | 12.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
3.1 | 12.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
3.1 | 18.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
3.1 | 3.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
3.1 | 6.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
3.1 | 18.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
3.1 | 18.5 | GO:0051639 | actin filament network formation(GO:0051639) |
3.1 | 9.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
3.1 | 15.3 | GO:0006563 | L-serine metabolic process(GO:0006563) |
3.1 | 3.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
3.1 | 36.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
3.1 | 3.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
3.1 | 9.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
3.1 | 12.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
3.0 | 9.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
3.0 | 12.1 | GO:0000237 | leptotene(GO:0000237) |
3.0 | 24.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
3.0 | 6.0 | GO:0019081 | viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
3.0 | 3.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
3.0 | 38.9 | GO:0048821 | erythrocyte development(GO:0048821) |
3.0 | 3.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
3.0 | 32.7 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
3.0 | 8.9 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
3.0 | 50.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
2.9 | 5.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
2.9 | 5.9 | GO:1902969 | mitotic DNA replication(GO:1902969) |
2.9 | 8.8 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
2.9 | 44.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
2.9 | 5.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.9 | 2.9 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
2.9 | 8.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
2.9 | 14.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
2.9 | 5.8 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
2.9 | 5.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
2.9 | 28.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
2.9 | 14.5 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
2.9 | 20.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
2.9 | 54.8 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
2.9 | 14.4 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
2.9 | 2.9 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
2.9 | 5.7 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
2.8 | 22.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
2.8 | 22.8 | GO:0009437 | carnitine metabolic process(GO:0009437) |
2.8 | 2.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
2.8 | 17.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
2.8 | 42.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
2.8 | 17.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
2.8 | 5.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.8 | 11.2 | GO:0009414 | response to water deprivation(GO:0009414) |
2.8 | 2.8 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
2.8 | 11.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.8 | 8.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
2.8 | 2.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
2.8 | 5.6 | GO:0010039 | response to iron ion(GO:0010039) |
2.8 | 2.8 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
2.8 | 11.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
2.8 | 11.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
2.8 | 5.5 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
2.8 | 2.8 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.8 | 33.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
2.7 | 8.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
2.7 | 5.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
2.7 | 2.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.7 | 2.7 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
2.7 | 2.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
2.7 | 2.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
2.7 | 8.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
2.7 | 8.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
2.7 | 5.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
2.7 | 21.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
2.7 | 5.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.7 | 5.4 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
2.7 | 8.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
2.7 | 8.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
2.7 | 8.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
2.7 | 2.7 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
2.7 | 8.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.7 | 8.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.7 | 8.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
2.7 | 8.0 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
2.7 | 29.4 | GO:0048535 | lymph node development(GO:0048535) |
2.7 | 82.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
2.7 | 16.0 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
2.7 | 5.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
2.7 | 29.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
2.7 | 18.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
2.7 | 21.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
2.7 | 21.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
2.7 | 10.6 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
2.6 | 2.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
2.6 | 13.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
2.6 | 15.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
2.6 | 23.8 | GO:0006298 | mismatch repair(GO:0006298) |
2.6 | 10.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
2.6 | 15.8 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
2.6 | 7.9 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
2.6 | 31.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
2.6 | 2.6 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
2.6 | 13.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
2.6 | 7.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.6 | 7.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
2.6 | 2.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
2.6 | 7.7 | GO:0003096 | renal sodium ion transport(GO:0003096) |
2.6 | 20.6 | GO:0006855 | drug transmembrane transport(GO:0006855) |
2.6 | 7.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
2.6 | 10.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
2.6 | 5.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.6 | 12.9 | GO:0070989 | oxidative demethylation(GO:0070989) |
2.6 | 23.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
2.6 | 2.6 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
2.6 | 5.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
2.6 | 35.8 | GO:0031648 | protein destabilization(GO:0031648) |
2.6 | 35.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
2.6 | 5.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
2.6 | 10.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
2.5 | 7.6 | GO:0048478 | replication fork protection(GO:0048478) |
2.5 | 2.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
2.5 | 7.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
2.5 | 15.2 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
2.5 | 2.5 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
2.5 | 2.5 | GO:0019042 | viral latency(GO:0019042) |
2.5 | 30.3 | GO:0071514 | genetic imprinting(GO:0071514) |
2.5 | 12.5 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
2.5 | 12.5 | GO:1904970 | brush border assembly(GO:1904970) |
2.5 | 42.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
2.5 | 29.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
2.5 | 19.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
2.5 | 37.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
2.5 | 12.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
2.5 | 2.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
2.5 | 5.0 | GO:0060056 | mammary gland involution(GO:0060056) |
2.5 | 12.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
2.5 | 22.3 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
2.5 | 7.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.5 | 12.4 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
2.5 | 14.8 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
2.5 | 4.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
2.5 | 7.4 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.5 | 22.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
2.5 | 4.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
2.5 | 4.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.5 | 14.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.5 | 7.4 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
2.5 | 2.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
2.4 | 17.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
2.4 | 4.9 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
2.4 | 2.4 | GO:0033044 | regulation of chromosome organization(GO:0033044) |
2.4 | 7.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.4 | 7.3 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
2.4 | 7.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
2.4 | 7.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
2.4 | 4.8 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
2.4 | 7.2 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
2.4 | 11.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
2.4 | 14.3 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
2.4 | 4.8 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
2.4 | 4.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
2.4 | 4.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
2.4 | 4.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
2.4 | 4.7 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
2.4 | 2.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
2.4 | 4.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
2.4 | 4.7 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.4 | 4.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
2.3 | 7.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
2.3 | 25.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
2.3 | 2.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
2.3 | 7.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
2.3 | 4.6 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
2.3 | 11.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
2.3 | 4.6 | GO:0033227 | dsRNA transport(GO:0033227) |
2.3 | 11.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.3 | 16.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
2.3 | 9.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
2.3 | 20.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
2.3 | 4.6 | GO:0006007 | glucose catabolic process(GO:0006007) |
2.3 | 2.3 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
2.3 | 2.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.3 | 2.3 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
2.3 | 6.8 | GO:0090110 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
2.3 | 2.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
2.3 | 18.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
2.3 | 9.1 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
2.3 | 2.3 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
2.3 | 13.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
2.3 | 13.5 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
2.3 | 2.3 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
2.2 | 20.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
2.2 | 13.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
2.2 | 6.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.2 | 11.2 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
2.2 | 24.5 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
2.2 | 6.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
2.2 | 2.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
2.2 | 2.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.2 | 17.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
2.2 | 6.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.2 | 2.2 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
2.2 | 2.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
2.2 | 6.6 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
2.2 | 78.8 | GO:0031929 | TOR signaling(GO:0031929) |
2.2 | 6.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
2.2 | 13.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
2.2 | 4.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
2.2 | 2.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
2.2 | 17.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
2.2 | 8.7 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
2.2 | 2.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.2 | 8.7 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
2.2 | 4.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
2.2 | 15.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
2.2 | 4.3 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
2.2 | 10.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
2.1 | 2.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
2.1 | 60.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
2.1 | 2.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
2.1 | 8.6 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
2.1 | 4.3 | GO:1901164 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) negative regulation of trophoblast cell migration(GO:1901164) |
2.1 | 2.1 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
2.1 | 2.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.1 | 10.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.1 | 23.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
2.1 | 6.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.1 | 4.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
2.1 | 2.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
2.1 | 4.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
2.1 | 14.8 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
2.1 | 36.0 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
2.1 | 12.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
2.1 | 4.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
2.1 | 21.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
2.1 | 10.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
2.1 | 2.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
2.1 | 6.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.1 | 4.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
2.1 | 16.7 | GO:0017014 | protein nitrosylation(GO:0017014) |
2.1 | 8.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
2.1 | 6.2 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
2.1 | 8.3 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
2.1 | 4.2 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
2.1 | 2.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
2.1 | 10.4 | GO:0097421 | liver regeneration(GO:0097421) |
2.1 | 2.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
2.1 | 6.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
2.0 | 18.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
2.0 | 8.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
2.0 | 4.1 | GO:1903232 | melanosome assembly(GO:1903232) |
2.0 | 2.0 | GO:0007398 | ectoderm development(GO:0007398) |
2.0 | 2.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
2.0 | 14.2 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
2.0 | 2.0 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
2.0 | 2.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
2.0 | 36.4 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
2.0 | 6.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
2.0 | 36.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
2.0 | 4.0 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
2.0 | 10.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
2.0 | 4.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
2.0 | 4.0 | GO:0010958 | regulation of amino acid import(GO:0010958) |
2.0 | 8.0 | GO:0000050 | urea cycle(GO:0000050) |
2.0 | 2.0 | GO:1990182 | exosomal secretion(GO:1990182) |
2.0 | 9.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
2.0 | 4.0 | GO:0015809 | arginine transport(GO:0015809) |
2.0 | 9.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
2.0 | 2.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
2.0 | 15.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
2.0 | 5.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
2.0 | 43.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
2.0 | 11.8 | GO:0030261 | chromosome condensation(GO:0030261) |
2.0 | 7.9 | GO:0000154 | rRNA modification(GO:0000154) |
2.0 | 2.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
2.0 | 2.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
2.0 | 33.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
2.0 | 5.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
2.0 | 3.9 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.9 | 25.3 | GO:0034728 | nucleosome organization(GO:0034728) |
1.9 | 11.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.9 | 5.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.9 | 15.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.9 | 3.9 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.9 | 17.5 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
1.9 | 1.9 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
1.9 | 21.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.9 | 1.9 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
1.9 | 11.6 | GO:0007379 | segment specification(GO:0007379) |
1.9 | 7.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.9 | 3.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.9 | 13.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.9 | 1.9 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.9 | 15.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.9 | 13.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.9 | 7.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
1.9 | 5.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.9 | 5.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.9 | 1.9 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
1.9 | 1.9 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.9 | 5.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
1.9 | 5.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.9 | 1.9 | GO:0002840 | negative regulation of T cell mediated cytotoxicity(GO:0001915) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.9 | 1.9 | GO:0015755 | fructose transport(GO:0015755) |
1.9 | 9.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.9 | 1.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
1.9 | 11.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
1.9 | 7.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.9 | 22.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
1.9 | 13.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.9 | 1.9 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.9 | 5.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
1.9 | 9.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.9 | 5.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
1.9 | 1.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.9 | 1.9 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.9 | 9.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.8 | 1.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.8 | 88.6 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
1.8 | 3.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.8 | 5.5 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
1.8 | 16.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.8 | 16.6 | GO:0001562 | response to protozoan(GO:0001562) |
1.8 | 3.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.8 | 3.7 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
1.8 | 3.7 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
1.8 | 7.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.8 | 1.8 | GO:0036257 | multivesicular body organization(GO:0036257) |
1.8 | 1.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.8 | 16.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
1.8 | 3.6 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
1.8 | 27.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.8 | 1.8 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.8 | 5.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.8 | 59.5 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
1.8 | 1.8 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
1.8 | 5.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
1.8 | 28.7 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
1.8 | 7.1 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
1.8 | 1.8 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.8 | 1.8 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.8 | 17.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.8 | 3.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.8 | 16.0 | GO:0006415 | translational termination(GO:0006415) |
1.8 | 10.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.8 | 14.2 | GO:0016926 | protein desumoylation(GO:0016926) |
1.8 | 5.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.8 | 5.3 | GO:0015802 | basic amino acid transport(GO:0015802) histidine transport(GO:0015817) |
1.8 | 8.8 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
1.8 | 15.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
1.8 | 3.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.8 | 5.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.8 | 12.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
1.8 | 5.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.8 | 1.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.8 | 5.3 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
1.7 | 15.7 | GO:0042407 | cristae formation(GO:0042407) |
1.7 | 5.2 | GO:0019695 | choline metabolic process(GO:0019695) |
1.7 | 8.7 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
1.7 | 17.4 | GO:0001893 | maternal placenta development(GO:0001893) |
1.7 | 12.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
1.7 | 3.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.7 | 8.7 | GO:0000012 | single strand break repair(GO:0000012) |
1.7 | 1.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
1.7 | 3.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.7 | 1.7 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
1.7 | 1.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.7 | 3.4 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
1.7 | 5.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.7 | 36.1 | GO:0007520 | myoblast fusion(GO:0007520) |
1.7 | 5.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.7 | 5.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.7 | 5.1 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
1.7 | 6.8 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
1.7 | 6.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.7 | 13.7 | GO:0071824 | protein-DNA complex assembly(GO:0065004) protein-DNA complex subunit organization(GO:0071824) |
1.7 | 8.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
1.7 | 3.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.7 | 6.8 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.7 | 1.7 | GO:0019086 | late viral transcription(GO:0019086) |
1.7 | 25.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.7 | 3.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.7 | 5.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
1.7 | 20.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
1.7 | 8.5 | GO:0051013 | microtubule severing(GO:0051013) |
1.7 | 18.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
1.7 | 1.7 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.7 | 23.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
1.7 | 3.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.7 | 3.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
1.7 | 3.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.7 | 3.3 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.7 | 1.7 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
1.6 | 3.3 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
1.6 | 28.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.6 | 3.3 | GO:0033260 | nuclear DNA replication(GO:0033260) |
1.6 | 3.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.6 | 41.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
1.6 | 3.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
1.6 | 1.6 | GO:0090042 | tubulin deacetylation(GO:0090042) |
1.6 | 1.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.6 | 1.6 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
1.6 | 1.6 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
1.6 | 13.1 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
1.6 | 13.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
1.6 | 9.8 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
1.6 | 118.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
1.6 | 1.6 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
1.6 | 6.5 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.6 | 8.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.6 | 6.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
1.6 | 6.5 | GO:0071569 | protein ufmylation(GO:0071569) |
1.6 | 30.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.6 | 4.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.6 | 1.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.6 | 4.8 | GO:0007000 | nucleolus organization(GO:0007000) |
1.6 | 48.4 | GO:0098840 | protein transport along microtubule(GO:0098840) |
1.6 | 3.2 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
1.6 | 25.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.6 | 11.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
1.6 | 8.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.6 | 11.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
1.6 | 17.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
1.6 | 8.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.6 | 43.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
1.6 | 1.6 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
1.6 | 52.4 | GO:0007030 | Golgi organization(GO:0007030) |
1.6 | 3.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.6 | 1.6 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
1.6 | 1.6 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
1.6 | 3.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.6 | 1.6 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
1.6 | 3.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.6 | 1.6 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
1.5 | 10.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
1.5 | 9.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.5 | 1.5 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.5 | 6.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
1.5 | 1.5 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
1.5 | 13.9 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
1.5 | 6.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.5 | 27.6 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
1.5 | 6.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.5 | 1.5 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
1.5 | 4.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
1.5 | 36.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
1.5 | 6.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
1.5 | 16.6 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
1.5 | 1.5 | GO:0010165 | response to X-ray(GO:0010165) |
1.5 | 7.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.5 | 1.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.5 | 1.5 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
1.5 | 3.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.5 | 10.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.5 | 8.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.5 | 181.2 | GO:0016568 | chromatin modification(GO:0016568) |
1.5 | 10.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
1.5 | 4.4 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
1.5 | 8.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
1.5 | 5.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.5 | 2.9 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
1.5 | 4.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.5 | 1.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.5 | 14.7 | GO:0045047 | protein targeting to ER(GO:0045047) |
1.5 | 1.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.5 | 2.9 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
1.5 | 7.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.5 | 18.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.5 | 26.1 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
1.5 | 29.0 | GO:0060323 | head morphogenesis(GO:0060323) |
1.4 | 1.4 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
1.4 | 5.7 | GO:0070542 | response to fatty acid(GO:0070542) |
1.4 | 2.9 | GO:0061042 | vascular wound healing(GO:0061042) |
1.4 | 5.7 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
1.4 | 1.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
1.4 | 28.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.4 | 11.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
1.4 | 1.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
1.4 | 7.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
1.4 | 7.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.4 | 4.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
1.4 | 15.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.4 | 4.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.4 | 8.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.4 | 4.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.4 | 45.9 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
1.4 | 2.8 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
1.4 | 1.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.4 | 23.5 | GO:0007569 | cell aging(GO:0007569) |
1.4 | 53.6 | GO:0051225 | spindle assembly(GO:0051225) |
1.4 | 12.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.4 | 4.1 | GO:0015705 | iodide transport(GO:0015705) |
1.4 | 2.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.4 | 13.6 | GO:0006284 | base-excision repair(GO:0006284) |
1.4 | 2.7 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
1.3 | 1.3 | GO:2000667 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
1.3 | 1.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.3 | 5.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.3 | 6.6 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
1.3 | 4.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.3 | 2.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.3 | 6.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.3 | 31.7 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
1.3 | 2.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.3 | 33.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.3 | 5.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
1.3 | 2.6 | GO:0034310 | ethanol catabolic process(GO:0006068) primary alcohol catabolic process(GO:0034310) |
1.3 | 2.6 | GO:0042255 | ribosome assembly(GO:0042255) |
1.3 | 22.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
1.3 | 1.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.3 | 3.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
1.3 | 22.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.3 | 2.6 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
1.3 | 3.9 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
1.3 | 1.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.3 | 9.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.3 | 2.6 | GO:0009650 | UV protection(GO:0009650) |
1.3 | 2.6 | GO:0018158 | protein oxidation(GO:0018158) |
1.3 | 15.4 | GO:0035904 | aorta development(GO:0035904) |
1.3 | 5.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.3 | 3.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.3 | 7.6 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
1.3 | 1.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.3 | 52.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
1.3 | 2.5 | GO:0006525 | arginine metabolic process(GO:0006525) |
1.3 | 6.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.3 | 3.8 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.3 | 2.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.3 | 6.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
1.2 | 2.5 | GO:0002215 | defense response to nematode(GO:0002215) |
1.2 | 6.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
1.2 | 3.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.2 | 1.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.2 | 5.0 | GO:0006405 | RNA export from nucleus(GO:0006405) |
1.2 | 7.4 | GO:0030033 | microvillus assembly(GO:0030033) |
1.2 | 1.2 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
1.2 | 8.6 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.2 | 3.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.2 | 11.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
1.2 | 2.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.2 | 8.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
1.2 | 2.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.2 | 6.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
1.2 | 12.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
1.2 | 7.3 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
1.2 | 25.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
1.2 | 3.6 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.2 | 1.2 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
1.2 | 2.4 | GO:0033762 | response to glucagon(GO:0033762) |
1.2 | 1.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
1.2 | 2.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.2 | 2.4 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
1.2 | 15.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.2 | 1.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.2 | 15.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
1.2 | 2.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.2 | 2.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.2 | 13.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
1.2 | 1.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
1.2 | 2.4 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
1.2 | 5.9 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
1.2 | 4.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
1.2 | 4.7 | GO:0032105 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
1.2 | 2.3 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
1.2 | 11.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
1.2 | 2.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
1.2 | 5.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.2 | 33.8 | GO:0031424 | keratinization(GO:0031424) |
1.2 | 5.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.2 | 6.9 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
1.2 | 10.4 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.2 | 34.5 | GO:0009060 | aerobic respiration(GO:0009060) |
1.1 | 3.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
1.1 | 9.2 | GO:0070166 | enamel mineralization(GO:0070166) |
1.1 | 3.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
1.1 | 3.4 | GO:0051451 | myoblast migration(GO:0051451) |
1.1 | 13.7 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
1.1 | 1.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
1.1 | 19.3 | GO:0051236 | establishment of RNA localization(GO:0051236) |
1.1 | 4.5 | GO:0032602 | chemokine production(GO:0032602) |
1.1 | 18.1 | GO:0070527 | platelet aggregation(GO:0070527) |
1.1 | 5.6 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
1.1 | 4.5 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
1.1 | 4.5 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) |
1.1 | 3.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
1.1 | 5.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.1 | 2.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.1 | 7.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
1.1 | 15.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
1.1 | 18.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
1.1 | 5.5 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.1 | 6.6 | GO:0048753 | pigment granule organization(GO:0048753) |
1.1 | 1.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
1.1 | 6.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.1 | 3.3 | GO:0036035 | osteoclast development(GO:0036035) |
1.1 | 1.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.1 | 4.4 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
1.1 | 1.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.1 | 2.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.1 | 4.3 | GO:0017085 | response to insecticide(GO:0017085) |
1.1 | 15.2 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
1.1 | 9.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
1.1 | 4.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.1 | 6.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.1 | 3.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
1.1 | 3.2 | GO:0071404 | response to lipoprotein particle(GO:0055094) cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.1 | 6.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.1 | 13.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.1 | 2.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.1 | 4.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.1 | 2.1 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
1.1 | 3.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.1 | 21.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
1.1 | 27.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.1 | 3.2 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
1.1 | 6.3 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
1.0 | 5.2 | GO:0006342 | chromatin silencing(GO:0006342) |
1.0 | 9.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.0 | 5.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
1.0 | 1.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.0 | 1.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.0 | 6.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.0 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.0 | 2.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
1.0 | 3.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
1.0 | 4.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.0 | 16.5 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
1.0 | 5.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
1.0 | 3.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.0 | 4.1 | GO:0046415 | urate metabolic process(GO:0046415) |
1.0 | 2.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.0 | 1.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
1.0 | 3.0 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
1.0 | 4.0 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
1.0 | 34.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
1.0 | 1.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.0 | 5.0 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.0 | 2.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.0 | 1.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
1.0 | 1.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.0 | 2.0 | GO:0007141 | male meiosis I(GO:0007141) |
1.0 | 3.0 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
1.0 | 1.0 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
1.0 | 4.9 | GO:0060539 | diaphragm development(GO:0060539) |
1.0 | 22.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.0 | 7.9 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
1.0 | 5.9 | GO:0032060 | bleb assembly(GO:0032060) |
1.0 | 2.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
1.0 | 6.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.0 | 1.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.0 | 1.9 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
1.0 | 1.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
1.0 | 2.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.0 | 3.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
1.0 | 8.6 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
1.0 | 1.0 | GO:0006949 | syncytium formation(GO:0006949) |
1.0 | 5.7 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
1.0 | 19.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
1.0 | 1.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
1.0 | 6.7 | GO:0051168 | nuclear export(GO:0051168) |
0.9 | 6.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.9 | 11.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.9 | 1.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.9 | 10.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.9 | 1.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.9 | 0.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.9 | 11.1 | GO:1901998 | toxin transport(GO:1901998) |
0.9 | 1.9 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.9 | 2.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 2.8 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.9 | 1.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.9 | 1.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.9 | 1.8 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.9 | 0.9 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.9 | 13.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.9 | 5.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.9 | 3.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.9 | 1.8 | GO:0044033 | multi-organism metabolic process(GO:0044033) |
0.9 | 3.6 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.9 | 0.9 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.9 | 1.8 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.9 | 1.8 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.9 | 7.0 | GO:0006414 | translational elongation(GO:0006414) |
0.9 | 1.8 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.9 | 25.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.9 | 2.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.9 | 1.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.9 | 0.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.9 | 5.2 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.9 | 12.9 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.9 | 9.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.9 | 0.9 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.9 | 6.0 | GO:0007099 | centriole replication(GO:0007099) |
0.8 | 2.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.8 | 0.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.8 | 5.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.8 | 4.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.8 | 1.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.8 | 10.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.8 | 1.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.8 | 22.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.8 | 3.3 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.8 | 157.2 | GO:0006412 | translation(GO:0006412) |
0.8 | 1.6 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.8 | 2.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.8 | 7.4 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.8 | 5.7 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.8 | 0.8 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.8 | 5.7 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.8 | 9.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.8 | 4.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.8 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.8 | 9.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.8 | 3.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.8 | 1.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.8 | 7.8 | GO:0051591 | response to cAMP(GO:0051591) |
0.8 | 0.8 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.8 | 0.8 | GO:0001555 | oocyte growth(GO:0001555) |
0.8 | 1.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.8 | 104.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.8 | 4.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.8 | 2.3 | GO:0007051 | spindle organization(GO:0007051) |
0.8 | 0.8 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.8 | 3.1 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.8 | 1.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.8 | 4.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.8 | 1.5 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.8 | 3.8 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.8 | 0.8 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.7 | 2.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.7 | 9.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.7 | 1.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.7 | 0.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.7 | 3.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.7 | 3.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.7 | 0.7 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.7 | 0.7 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.7 | 10.8 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.7 | 4.3 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.7 | 2.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.7 | 0.7 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.7 | 2.8 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.7 | 1.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.7 | 2.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.7 | 0.7 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.7 | 0.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.7 | 2.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.7 | 0.7 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.7 | 0.7 | GO:0015677 | copper ion import(GO:0015677) |
0.7 | 6.3 | GO:0019079 | viral genome replication(GO:0019079) |
0.7 | 2.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.7 | 3.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.7 | 2.7 | GO:0007088 | regulation of mitotic nuclear division(GO:0007088) |
0.7 | 3.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.7 | 5.4 | GO:0061515 | myeloid cell development(GO:0061515) |
0.7 | 2.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.7 | 11.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.7 | 3.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.7 | 6.7 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.7 | 1.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.7 | 2.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.7 | 2.0 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.6 | 1.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.6 | 3.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.6 | 3.2 | GO:0007098 | centrosome cycle(GO:0007098) |
0.6 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 5.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.6 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.6 | 1.9 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.6 | 1.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.6 | 8.8 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.6 | 87.8 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.6 | 1.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 0.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.6 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.6 | 0.6 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.6 | 0.6 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.6 | 1.2 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 0.6 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.6 | 0.6 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.6 | 1.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.6 | 4.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.6 | 3.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.6 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 2.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.6 | 1.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.6 | 1.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 1.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.6 | 0.6 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.6 | 0.6 | GO:0032252 | secretory granule localization(GO:0032252) |
0.6 | 1.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.6 | 0.6 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.6 | 2.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 7.2 | GO:0051923 | sulfation(GO:0051923) |
0.5 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 1.1 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.5 | 0.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.5 | 50.9 | GO:0006396 | RNA processing(GO:0006396) |
0.5 | 0.5 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.5 | 4.3 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.5 | 0.5 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.5 | 2.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.5 | 1.0 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.5 | 1.0 | GO:0097531 | mast cell migration(GO:0097531) |
0.5 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 0.5 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.5 | 1.0 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.5 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.5 | 0.5 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.5 | 1.0 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 23.5 | GO:0006281 | DNA repair(GO:0006281) |
0.5 | 2.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.5 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.5 | 1.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 3.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.5 | 0.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 4.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.5 | 0.5 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.5 | 2.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.4 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.4 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 1.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.4 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.4 | 0.9 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.4 | 5.2 | GO:1905037 | autophagosome organization(GO:1905037) |
0.4 | 1.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.4 | 0.4 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.4 | 5.1 | GO:0019835 | cytolysis(GO:0019835) |
0.4 | 1.7 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.4 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 6.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.4 | 0.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.4 | 1.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 1.6 | GO:0032355 | response to estradiol(GO:0032355) |
0.4 | 6.5 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.4 | 2.4 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.4 | 3.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.4 | 4.8 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.4 | 0.4 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.4 | 0.8 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.4 | 0.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 1.5 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.4 | 5.2 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.4 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 0.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 0.7 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 0.7 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.4 | 1.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 0.7 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.4 | 1.4 | GO:0042116 | macrophage activation(GO:0042116) |
0.4 | 1.4 | GO:0048599 | oocyte development(GO:0048599) |
0.4 | 0.4 | GO:0060287 | glandular epithelial cell maturation(GO:0002071) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 1.0 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.0 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.3 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.3 | 3.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.3 | 0.3 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.3 | 2.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 0.3 | GO:0043038 | amino acid activation(GO:0043038) |
0.3 | 1.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 0.6 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 0.9 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 9.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.3 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.3 | 3.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 0.3 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.3 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 1.8 | GO:0050892 | intestinal absorption(GO:0050892) |
0.3 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.6 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 1.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 0.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.3 | 2.6 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 0.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 0.8 | GO:0072678 | T cell migration(GO:0072678) |
0.3 | 20.5 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.3 | 5.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.3 | 5.2 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.3 | 0.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 3.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.3 | 10.1 | GO:0032259 | methylation(GO:0032259) |
0.3 | 1.3 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.2 | 2.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.7 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.2 | 0.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 1.6 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.2 | 1.6 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.2 | 0.4 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.2 | 6.9 | GO:0006956 | complement activation(GO:0006956) |
0.2 | 0.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 0.7 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 1.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 1.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 11.8 | GO:0051607 | defense response to virus(GO:0051607) |
0.2 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.2 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 1.9 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 0.2 | GO:0006323 | DNA packaging(GO:0006323) |
0.2 | 0.2 | GO:0098792 | xenophagy(GO:0098792) |
0.2 | 1.0 | GO:0035601 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.2 | 1.0 | GO:0051297 | centrosome organization(GO:0051297) |
0.2 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 0.2 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.2 | 2.3 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.2 | 0.6 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.2 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.4 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.2 | 9.5 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.2 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 4.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.2 | 0.7 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 0.3 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.2 | GO:0045912 | negative regulation of carbohydrate metabolic process(GO:0045912) |
0.1 | 1.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.2 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.1 | 0.1 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.1 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.2 | GO:0071599 | otic vesicle development(GO:0071599) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.1 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.1 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 0.2 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 3.0 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.1 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.3 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.2 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 4.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.1 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.0 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.0 | 2.7 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.0 | 76.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
17.2 | 68.8 | GO:0072487 | MSL complex(GO:0072487) |
14.4 | 86.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
14.3 | 43.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
14.3 | 114.3 | GO:0001650 | fibrillar center(GO:0001650) |
13.9 | 69.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
13.7 | 54.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
13.5 | 13.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
13.5 | 40.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
13.3 | 39.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
12.3 | 36.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
12.0 | 59.9 | GO:0005638 | lamin filament(GO:0005638) |
11.2 | 33.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
11.1 | 144.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
10.9 | 54.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
10.2 | 40.9 | GO:0005642 | annulate lamellae(GO:0005642) |
9.9 | 69.6 | GO:0042382 | paraspeckles(GO:0042382) |
9.7 | 48.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
9.7 | 87.0 | GO:0090544 | BAF-type complex(GO:0090544) |
9.7 | 57.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
9.1 | 27.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
9.0 | 35.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
9.0 | 35.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
8.8 | 35.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
8.8 | 61.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
8.7 | 26.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
8.2 | 24.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
8.2 | 24.5 | GO:0031523 | Myb complex(GO:0031523) |
7.9 | 55.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
7.9 | 23.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
7.9 | 55.1 | GO:0031931 | TORC1 complex(GO:0031931) |
7.6 | 22.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
7.5 | 60.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
7.4 | 14.8 | GO:0001739 | sex chromatin(GO:0001739) |
7.3 | 80.2 | GO:0035102 | PRC1 complex(GO:0035102) |
7.2 | 43.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
7.2 | 21.6 | GO:0000811 | GINS complex(GO:0000811) |
7.1 | 28.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
6.9 | 55.5 | GO:0030056 | hemidesmosome(GO:0030056) |
6.9 | 207.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
6.7 | 6.7 | GO:0097427 | microtubule bundle(GO:0097427) |
6.7 | 369.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
6.7 | 100.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
6.7 | 187.2 | GO:0031519 | PcG protein complex(GO:0031519) |
6.6 | 59.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
6.6 | 6.6 | GO:0051233 | spindle midzone(GO:0051233) |
6.4 | 38.5 | GO:0001940 | male pronucleus(GO:0001940) |
6.4 | 25.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
6.3 | 25.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
6.3 | 12.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
6.2 | 12.4 | GO:0001939 | female pronucleus(GO:0001939) |
6.2 | 12.4 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
6.2 | 12.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
6.1 | 258.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
6.1 | 49.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
6.1 | 18.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
6.0 | 18.0 | GO:0031417 | NatC complex(GO:0031417) |
6.0 | 18.0 | GO:1990635 | proximal dendrite(GO:1990635) |
5.9 | 11.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
5.9 | 11.7 | GO:0030870 | Mre11 complex(GO:0030870) |
5.7 | 11.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
5.6 | 28.2 | GO:0044194 | cytolytic granule(GO:0044194) |
5.6 | 22.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
5.5 | 116.5 | GO:0000786 | nucleosome(GO:0000786) |
5.5 | 16.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
5.5 | 11.1 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
5.5 | 33.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
5.5 | 21.9 | GO:1990130 | Iml1 complex(GO:1990130) |
5.4 | 80.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
5.2 | 26.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
5.2 | 20.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
5.2 | 31.4 | GO:0005818 | aster(GO:0005818) |
5.2 | 108.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
5.1 | 15.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
5.1 | 15.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
5.1 | 56.1 | GO:0070938 | contractile ring(GO:0070938) |
5.1 | 50.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
5.1 | 20.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
5.0 | 10.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
5.0 | 69.5 | GO:0031528 | microvillus membrane(GO:0031528) |
4.9 | 4.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
4.9 | 34.3 | GO:0016600 | flotillin complex(GO:0016600) |
4.9 | 14.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
4.9 | 14.6 | GO:0097452 | GAIT complex(GO:0097452) |
4.9 | 14.6 | GO:1990423 | RZZ complex(GO:1990423) |
4.9 | 14.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
4.8 | 28.9 | GO:0031415 | NatA complex(GO:0031415) |
4.8 | 14.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
4.8 | 71.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
4.8 | 19.1 | GO:0042825 | TAP complex(GO:0042825) |
4.7 | 37.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
4.7 | 37.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
4.7 | 14.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
4.6 | 51.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
4.6 | 189.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
4.6 | 13.9 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
4.6 | 13.8 | GO:0005955 | calcineurin complex(GO:0005955) |
4.6 | 55.1 | GO:0030914 | STAGA complex(GO:0030914) |
4.6 | 303.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
4.6 | 13.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
4.5 | 86.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
4.5 | 36.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
4.5 | 36.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
4.5 | 36.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
4.5 | 72.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
4.5 | 49.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
4.5 | 49.0 | GO:0032039 | integrator complex(GO:0032039) |
4.4 | 17.6 | GO:0030689 | Noc complex(GO:0030689) |
4.4 | 39.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
4.4 | 13.1 | GO:0097443 | sorting endosome(GO:0097443) |
4.4 | 34.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
4.3 | 34.6 | GO:0097470 | ribbon synapse(GO:0097470) |
4.3 | 13.0 | GO:0035061 | interchromatin granule(GO:0035061) |
4.3 | 30.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
4.3 | 4.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
4.3 | 34.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
4.2 | 8.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
4.2 | 42.3 | GO:0045120 | pronucleus(GO:0045120) |
4.2 | 8.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
4.2 | 33.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
4.2 | 58.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
4.2 | 20.8 | GO:0005683 | U7 snRNP(GO:0005683) |
4.1 | 29.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
4.1 | 4.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
4.1 | 12.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
4.0 | 202.4 | GO:0016363 | nuclear matrix(GO:0016363) |
4.0 | 20.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
4.0 | 24.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
4.0 | 52.0 | GO:0000242 | pericentriolar material(GO:0000242) |
4.0 | 4.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
4.0 | 198.2 | GO:0016605 | PML body(GO:0016605) |
3.9 | 264.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
3.9 | 102.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
3.9 | 3.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
3.9 | 11.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
3.9 | 50.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
3.8 | 3.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
3.8 | 7.7 | GO:0097413 | Lewy body(GO:0097413) |
3.8 | 11.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
3.7 | 11.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
3.7 | 11.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
3.7 | 22.2 | GO:0034709 | methylosome(GO:0034709) |
3.7 | 3.7 | GO:0071817 | MMXD complex(GO:0071817) |
3.7 | 76.8 | GO:0034399 | nuclear periphery(GO:0034399) |
3.6 | 10.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
3.6 | 14.5 | GO:0000322 | storage vacuole(GO:0000322) |
3.6 | 36.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
3.6 | 10.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
3.6 | 10.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
3.6 | 93.9 | GO:0016592 | mediator complex(GO:0016592) |
3.6 | 14.2 | GO:0005657 | replication fork(GO:0005657) |
3.5 | 24.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
3.5 | 105.7 | GO:0005876 | spindle microtubule(GO:0005876) |
3.5 | 24.7 | GO:0070652 | HAUS complex(GO:0070652) |
3.5 | 10.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
3.5 | 28.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
3.5 | 3.5 | GO:0044327 | dendritic spine head(GO:0044327) |
3.5 | 17.5 | GO:0061617 | MICOS complex(GO:0061617) |
3.5 | 17.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
3.5 | 34.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
3.5 | 132.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
3.5 | 3.5 | GO:0061574 | ASAP complex(GO:0061574) |
3.4 | 17.2 | GO:0090543 | Flemming body(GO:0090543) |
3.4 | 27.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
3.4 | 3.4 | GO:0005687 | U4 snRNP(GO:0005687) |
3.4 | 3.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
3.4 | 10.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
3.4 | 40.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
3.4 | 6.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
3.4 | 30.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
3.4 | 50.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
3.4 | 10.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
3.4 | 13.4 | GO:0089701 | U2AF(GO:0089701) |
3.4 | 43.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
3.3 | 26.8 | GO:0005861 | troponin complex(GO:0005861) |
3.3 | 43.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
3.3 | 16.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
3.3 | 43.2 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
3.3 | 19.9 | GO:0042587 | glycogen granule(GO:0042587) |
3.3 | 29.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
3.3 | 19.7 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
3.3 | 9.8 | GO:0098536 | deuterosome(GO:0098536) |
3.2 | 135.8 | GO:0005643 | nuclear pore(GO:0005643) |
3.2 | 3.2 | GO:0071203 | WASH complex(GO:0071203) |
3.2 | 6.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
3.2 | 12.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
3.2 | 9.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
3.2 | 9.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
3.1 | 6.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
3.1 | 9.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
3.1 | 6.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.1 | 34.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
3.1 | 9.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
3.1 | 18.5 | GO:0010369 | chromocenter(GO:0010369) |
3.1 | 12.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
3.1 | 15.4 | GO:0097422 | tubular endosome(GO:0097422) |
3.1 | 67.6 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
3.1 | 3.1 | GO:1903349 | omegasome membrane(GO:1903349) |
3.1 | 27.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
3.1 | 6.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
3.0 | 6.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
3.0 | 6.1 | GO:1990391 | DNA repair complex(GO:1990391) |
3.0 | 141.8 | GO:0016459 | myosin complex(GO:0016459) |
3.0 | 15.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
3.0 | 324.2 | GO:0016604 | nuclear body(GO:0016604) |
3.0 | 62.9 | GO:0008305 | integrin complex(GO:0008305) |
3.0 | 23.9 | GO:0005682 | U5 snRNP(GO:0005682) |
3.0 | 9.0 | GO:0005745 | m-AAA complex(GO:0005745) |
3.0 | 38.8 | GO:0002102 | podosome(GO:0002102) |
3.0 | 122.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
3.0 | 32.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.9 | 8.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.9 | 22.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
2.8 | 22.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
2.8 | 39.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
2.8 | 28.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.8 | 11.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
2.8 | 5.6 | GO:1990923 | PET complex(GO:1990923) |
2.8 | 8.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.8 | 22.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
2.8 | 19.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
2.8 | 25.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.8 | 83.1 | GO:0005776 | autophagosome(GO:0005776) |
2.8 | 2.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.8 | 105.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
2.7 | 120.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
2.7 | 43.7 | GO:0043034 | costamere(GO:0043034) |
2.7 | 13.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
2.7 | 5.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
2.7 | 13.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
2.7 | 13.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
2.7 | 10.6 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
2.6 | 7.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
2.6 | 21.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
2.6 | 10.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
2.6 | 10.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
2.6 | 23.3 | GO:0030904 | retromer complex(GO:0030904) |
2.6 | 454.0 | GO:0000785 | chromatin(GO:0000785) |
2.6 | 15.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
2.6 | 120.9 | GO:0005811 | lipid particle(GO:0005811) |
2.6 | 12.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.6 | 15.3 | GO:0038201 | TOR complex(GO:0038201) |
2.5 | 32.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
2.5 | 10.1 | GO:0000796 | condensin complex(GO:0000796) |
2.5 | 5.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
2.5 | 24.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
2.4 | 2685.9 | GO:0005654 | nucleoplasm(GO:0005654) |
2.4 | 14.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
2.4 | 9.4 | GO:0000938 | GARP complex(GO:0000938) |
2.3 | 13.8 | GO:0034464 | BBSome(GO:0034464) |
2.3 | 4.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
2.3 | 29.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
2.3 | 2.3 | GO:0000346 | transcription export complex(GO:0000346) |
2.2 | 319.6 | GO:0005694 | chromosome(GO:0005694) |
2.2 | 8.9 | GO:0036128 | CatSper complex(GO:0036128) |
2.2 | 11.1 | GO:0031983 | vesicle lumen(GO:0031983) |
2.2 | 63.8 | GO:0005844 | polysome(GO:0005844) |
2.2 | 8.8 | GO:0036452 | ESCRT complex(GO:0036452) |
2.2 | 6.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
2.2 | 10.9 | GO:0000974 | Prp19 complex(GO:0000974) |
2.1 | 6.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
2.1 | 6.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.1 | 4.2 | GO:0097255 | R2TP complex(GO:0097255) |
2.1 | 6.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
2.1 | 6.2 | GO:0042583 | chromaffin granule(GO:0042583) |
2.1 | 14.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
2.1 | 10.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
2.0 | 42.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
2.0 | 14.1 | GO:0042588 | zymogen granule(GO:0042588) |
2.0 | 4.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
2.0 | 4.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
2.0 | 22.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.0 | 11.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
2.0 | 15.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
2.0 | 2.0 | GO:0042827 | platelet dense granule(GO:0042827) |
2.0 | 166.4 | GO:0072562 | blood microparticle(GO:0072562) |
2.0 | 3.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.9 | 79.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.9 | 3.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.9 | 65.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.9 | 3.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.9 | 28.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.9 | 1.9 | GO:0016939 | kinesin II complex(GO:0016939) |
1.9 | 192.6 | GO:0005667 | transcription factor complex(GO:0005667) |
1.9 | 3.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.9 | 11.2 | GO:0005916 | fascia adherens(GO:0005916) |
1.9 | 28.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.9 | 9.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.9 | 14.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.8 | 12.9 | GO:0033263 | CORVET complex(GO:0033263) |
1.8 | 3.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.8 | 7.3 | GO:0005869 | dynactin complex(GO:0005869) |
1.8 | 203.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.8 | 7.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.8 | 5.5 | GO:0048179 | activin receptor complex(GO:0048179) |
1.8 | 10.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.8 | 7.2 | GO:0005796 | Golgi lumen(GO:0005796) |
1.8 | 3.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.8 | 3.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.8 | 579.7 | GO:0005730 | nucleolus(GO:0005730) |
1.8 | 1.8 | GO:0071437 | invadopodium(GO:0071437) |
1.8 | 5.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.8 | 5.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.8 | 5.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.8 | 1.8 | GO:0043218 | compact myelin(GO:0043218) |
1.8 | 82.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.7 | 3.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.7 | 28.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.7 | 10.1 | GO:0070852 | cell body fiber(GO:0070852) |
1.7 | 1.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.7 | 53.4 | GO:0005902 | microvillus(GO:0005902) |
1.6 | 16.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.6 | 75.3 | GO:0005814 | centriole(GO:0005814) |
1.6 | 3.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.6 | 8.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.6 | 9.5 | GO:0046930 | pore complex(GO:0046930) |
1.6 | 6.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.6 | 9.5 | GO:0042599 | lamellar body(GO:0042599) |
1.6 | 4.7 | GO:0043293 | apoptosome(GO:0043293) |
1.6 | 1.6 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.6 | 4.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.6 | 6.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.6 | 10.9 | GO:0005771 | multivesicular body(GO:0005771) |
1.5 | 13.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.5 | 1.5 | GO:0005686 | U2 snRNP(GO:0005686) |
1.5 | 3.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.5 | 9.1 | GO:0010008 | endosome membrane(GO:0010008) |
1.5 | 15.1 | GO:0034451 | centriolar satellite(GO:0034451) |
1.5 | 7.5 | GO:0097342 | ripoptosome(GO:0097342) |
1.5 | 15.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.5 | 7.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.5 | 7.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.5 | 41.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.5 | 5.9 | GO:0071953 | elastic fiber(GO:0071953) |
1.5 | 14.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.5 | 46.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.5 | 4.4 | GO:0071797 | LUBAC complex(GO:0071797) |
1.4 | 21.7 | GO:0000145 | exocyst(GO:0000145) |
1.4 | 232.7 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
1.4 | 5.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.4 | 4.3 | GO:0071986 | Ragulator complex(GO:0071986) |
1.4 | 114.2 | GO:0031965 | nuclear membrane(GO:0031965) |
1.4 | 9.9 | GO:0097225 | sperm midpiece(GO:0097225) |
1.4 | 36.3 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
1.4 | 23.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.3 | 2.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.3 | 26.9 | GO:0097228 | sperm principal piece(GO:0097228) |
1.3 | 14.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.3 | 4.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.3 | 11.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.3 | 1.3 | GO:0042585 | germinal vesicle(GO:0042585) |
1.3 | 2.6 | GO:0070820 | tertiary granule(GO:0070820) |
1.3 | 1.3 | GO:0031512 | motile primary cilium(GO:0031512) |
1.3 | 25.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
1.2 | 6.2 | GO:0031430 | M band(GO:0031430) |
1.2 | 7.5 | GO:0031209 | SCAR complex(GO:0031209) |
1.2 | 1.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.2 | 330.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.2 | 2.4 | GO:0097441 | basilar dendrite(GO:0097441) |
1.2 | 9.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.2 | 13.2 | GO:0043196 | varicosity(GO:0043196) |
1.2 | 898.2 | GO:0005829 | cytosol(GO:0005829) |
1.2 | 13.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.1 | 4.6 | GO:0035339 | SPOTS complex(GO:0035339) |
1.1 | 8.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
1.1 | 3.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.1 | 24.7 | GO:0030496 | midbody(GO:0030496) |
1.1 | 73.1 | GO:0005840 | ribosome(GO:0005840) |
1.1 | 36.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.0 | 55.4 | GO:0005903 | brush border(GO:0005903) |
1.0 | 1.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.0 | 40.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
1.0 | 4.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.0 | 3.0 | GO:0044292 | dendrite terminus(GO:0044292) |
1.0 | 20.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
1.0 | 1.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.0 | 2.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.0 | 7.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.9 | 147.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.9 | 30.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.9 | 3.8 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.9 | 14.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.9 | 1.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.9 | 2.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 3.7 | GO:0071546 | pi-body(GO:0071546) |
0.9 | 18.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.9 | 31.2 | GO:0045095 | keratin filament(GO:0045095) |
0.9 | 1.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.8 | 2.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.8 | 0.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.8 | 6.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.8 | 377.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.8 | 6.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.8 | 3.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.8 | 0.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.8 | 2.3 | GO:0042641 | actomyosin(GO:0042641) |
0.8 | 1556.2 | GO:0005634 | nucleus(GO:0005634) |
0.7 | 17.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.7 | 18.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.7 | 7.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.7 | 6.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 2.0 | GO:0043203 | axon hillock(GO:0043203) |
0.7 | 6.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.7 | 9.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.6 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 6.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.6 | 4.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.6 | 0.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.6 | 2.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 2.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 14.1 | GO:0031514 | motile cilium(GO:0031514) |
0.5 | 13.5 | GO:0005938 | cell cortex(GO:0005938) |
0.5 | 8.2 | GO:0030286 | dynein complex(GO:0030286) |
0.5 | 44.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.5 | 18.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.4 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 4.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 3.6 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 18.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 16.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.4 | 2.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 329.6 | GO:0070062 | extracellular exosome(GO:0070062) |
0.4 | 2.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.4 | 0.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 1.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 0.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.3 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 1.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 0.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.2 | 5.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 7.9 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 34.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.0 | 100.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
20.8 | 124.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
20.1 | 60.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
19.7 | 98.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
19.2 | 57.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
17.8 | 160.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
15.4 | 46.2 | GO:0050692 | DBD domain binding(GO:0050692) |
13.3 | 53.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
12.6 | 50.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
12.3 | 49.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
12.2 | 36.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
12.0 | 60.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
11.7 | 46.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
11.7 | 81.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
11.7 | 93.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
11.5 | 34.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
11.4 | 11.4 | GO:0051425 | PTB domain binding(GO:0051425) |
11.4 | 34.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
11.0 | 43.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
10.8 | 10.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
10.5 | 177.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
10.4 | 31.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
10.4 | 31.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
10.3 | 30.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
10.2 | 40.7 | GO:0009374 | biotin binding(GO:0009374) |
10.1 | 30.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
10.0 | 40.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
9.8 | 9.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
9.8 | 9.8 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
9.5 | 66.7 | GO:0000339 | RNA cap binding(GO:0000339) |
9.1 | 45.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
9.0 | 9.0 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
8.9 | 53.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
8.9 | 26.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
8.9 | 26.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
8.8 | 17.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
8.6 | 25.8 | GO:1990188 | euchromatin binding(GO:1990188) |
8.3 | 25.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
8.3 | 33.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
8.2 | 8.2 | GO:0034618 | arginine binding(GO:0034618) |
8.2 | 24.5 | GO:0030519 | snoRNP binding(GO:0030519) |
8.1 | 24.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
8.0 | 16.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
8.0 | 24.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
8.0 | 8.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
7.9 | 31.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
7.9 | 102.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
7.8 | 117.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
7.6 | 30.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
7.6 | 22.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
7.5 | 22.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
7.5 | 150.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
7.5 | 29.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
7.4 | 22.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
7.4 | 22.3 | GO:0005119 | smoothened binding(GO:0005119) |
7.3 | 22.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
7.3 | 29.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
7.2 | 43.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
7.2 | 28.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
7.2 | 136.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
7.2 | 36.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
7.2 | 21.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
7.1 | 78.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
7.1 | 28.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
7.0 | 21.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
7.0 | 69.9 | GO:0031491 | nucleosome binding(GO:0031491) |
6.9 | 20.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
6.9 | 41.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
6.9 | 68.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
6.9 | 20.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
6.8 | 41.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
6.8 | 27.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
6.8 | 20.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
6.8 | 20.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
6.8 | 27.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
6.7 | 33.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
6.7 | 26.7 | GO:0015232 | heme transporter activity(GO:0015232) |
6.7 | 20.0 | GO:0004064 | arylesterase activity(GO:0004064) |
6.7 | 20.0 | GO:0019961 | interferon binding(GO:0019961) |
6.6 | 33.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
6.6 | 19.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
6.6 | 85.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
6.6 | 45.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
6.5 | 6.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
6.5 | 25.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
6.5 | 25.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
6.5 | 19.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
6.4 | 31.9 | GO:0031013 | troponin I binding(GO:0031013) |
6.3 | 25.3 | GO:0005534 | galactose binding(GO:0005534) |
6.3 | 56.7 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
6.3 | 69.3 | GO:0017166 | vinculin binding(GO:0017166) |
6.3 | 37.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
6.3 | 25.0 | GO:0000182 | rDNA binding(GO:0000182) |
6.2 | 31.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
6.2 | 74.8 | GO:0044548 | S100 protein binding(GO:0044548) |
6.2 | 267.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
6.2 | 18.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
6.1 | 24.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
6.1 | 54.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
6.1 | 18.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
6.1 | 6.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
6.0 | 12.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
6.0 | 18.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
6.0 | 30.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
6.0 | 54.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
6.0 | 23.9 | GO:0036033 | mediator complex binding(GO:0036033) |
6.0 | 29.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
6.0 | 35.8 | GO:0034046 | poly(G) binding(GO:0034046) |
5.9 | 41.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
5.9 | 17.8 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
5.9 | 35.5 | GO:0030274 | LIM domain binding(GO:0030274) |
5.9 | 76.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
5.8 | 17.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
5.8 | 168.9 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
5.8 | 127.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
5.8 | 58.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
5.8 | 23.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
5.8 | 17.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
5.7 | 17.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
5.7 | 28.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
5.7 | 5.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
5.6 | 242.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
5.6 | 22.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
5.6 | 16.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
5.6 | 16.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
5.6 | 16.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
5.5 | 22.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
5.5 | 11.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
5.5 | 60.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
5.5 | 22.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
5.5 | 33.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
5.5 | 55.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
5.5 | 16.5 | GO:0019002 | GMP binding(GO:0019002) |
5.5 | 10.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
5.4 | 54.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
5.4 | 5.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
5.4 | 5.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
5.4 | 16.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
5.4 | 135.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
5.4 | 21.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
5.4 | 64.6 | GO:0008143 | poly(A) binding(GO:0008143) |
5.4 | 21.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
5.3 | 42.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
5.3 | 47.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
5.3 | 15.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
5.3 | 15.8 | GO:0030984 | kininogen binding(GO:0030984) |
5.2 | 15.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
5.2 | 5.2 | GO:0016015 | morphogen activity(GO:0016015) |
5.2 | 20.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
5.1 | 10.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
5.1 | 60.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
5.1 | 35.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
5.1 | 45.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
5.1 | 5.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
5.0 | 70.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
4.9 | 24.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
4.9 | 24.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
4.9 | 73.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
4.9 | 29.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
4.8 | 77.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
4.8 | 43.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
4.8 | 120.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
4.8 | 19.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
4.8 | 43.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
4.8 | 52.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
4.8 | 14.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
4.8 | 4.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
4.8 | 23.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
4.8 | 90.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
4.8 | 14.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
4.7 | 18.9 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
4.7 | 18.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
4.7 | 23.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
4.7 | 37.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
4.7 | 47.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
4.7 | 14.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
4.7 | 51.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
4.7 | 32.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
4.7 | 42.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
4.7 | 4.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
4.6 | 37.2 | GO:0008430 | selenium binding(GO:0008430) |
4.6 | 78.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
4.6 | 18.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
4.6 | 13.8 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
4.5 | 18.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
4.5 | 27.2 | GO:0036122 | BMP binding(GO:0036122) |
4.5 | 9.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
4.5 | 22.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
4.5 | 18.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
4.5 | 18.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
4.5 | 17.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
4.5 | 13.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
4.5 | 17.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
4.5 | 26.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
4.4 | 4.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
4.4 | 30.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
4.4 | 39.4 | GO:0031996 | thioesterase binding(GO:0031996) |
4.4 | 13.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
4.4 | 17.5 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
4.4 | 8.7 | GO:0030619 | U1 snRNA binding(GO:0030619) |
4.3 | 13.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
4.3 | 8.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
4.3 | 12.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
4.3 | 29.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
4.3 | 17.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
4.3 | 25.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
4.3 | 4.3 | GO:0043559 | insulin binding(GO:0043559) |
4.2 | 55.0 | GO:0005521 | lamin binding(GO:0005521) |
4.2 | 12.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
4.2 | 12.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
4.2 | 12.5 | GO:0004359 | glutaminase activity(GO:0004359) |
4.2 | 16.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
4.2 | 12.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
4.1 | 49.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
4.1 | 12.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
4.1 | 12.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
4.1 | 12.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
4.1 | 41.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
4.1 | 16.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
4.1 | 123.4 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
4.1 | 4.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
4.1 | 16.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
4.1 | 12.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
4.1 | 32.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
4.0 | 4.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
4.0 | 16.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
4.0 | 8.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
4.0 | 23.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
3.9 | 27.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
3.9 | 11.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
3.9 | 7.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
3.9 | 7.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
3.9 | 23.6 | GO:1990405 | protein antigen binding(GO:1990405) |
3.9 | 27.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
3.9 | 15.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
3.9 | 19.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
3.9 | 7.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
3.9 | 11.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
3.9 | 19.5 | GO:0070728 | leucine binding(GO:0070728) |
3.9 | 58.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
3.9 | 11.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
3.9 | 3.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
3.9 | 73.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
3.8 | 133.9 | GO:0035064 | methylated histone binding(GO:0035064) |
3.8 | 3.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
3.8 | 3.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
3.8 | 15.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
3.8 | 26.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
3.7 | 22.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
3.7 | 7.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
3.7 | 111.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
3.7 | 11.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
3.7 | 3.7 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
3.7 | 26.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
3.7 | 11.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
3.7 | 84.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
3.7 | 7.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
3.7 | 25.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
3.7 | 18.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
3.7 | 21.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
3.6 | 18.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
3.6 | 25.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
3.6 | 18.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
3.6 | 7.2 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
3.6 | 7.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
3.6 | 32.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
3.6 | 21.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
3.6 | 17.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
3.6 | 32.0 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
3.6 | 17.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
3.5 | 7.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
3.5 | 17.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
3.5 | 10.5 | GO:0070061 | fructose binding(GO:0070061) |
3.5 | 38.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
3.5 | 87.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
3.5 | 10.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
3.4 | 491.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
3.4 | 10.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
3.4 | 23.8 | GO:0046790 | virion binding(GO:0046790) |
3.4 | 33.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
3.4 | 47.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
3.4 | 6.8 | GO:0031014 | troponin T binding(GO:0031014) |
3.4 | 10.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
3.4 | 6.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
3.4 | 13.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
3.3 | 16.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
3.3 | 6.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
3.3 | 33.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
3.3 | 19.8 | GO:0015288 | porin activity(GO:0015288) |
3.3 | 174.1 | GO:0042393 | histone binding(GO:0042393) |
3.3 | 6.6 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
3.3 | 19.7 | GO:0008494 | translation activator activity(GO:0008494) |
3.3 | 19.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
3.3 | 13.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.3 | 29.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
3.2 | 6.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
3.2 | 12.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
3.2 | 48.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
3.2 | 19.2 | GO:0050733 | RS domain binding(GO:0050733) |
3.2 | 121.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
3.2 | 16.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
3.2 | 48.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
3.2 | 9.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.2 | 9.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
3.2 | 3.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
3.2 | 37.9 | GO:0005123 | death receptor binding(GO:0005123) |
3.1 | 25.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
3.1 | 15.7 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
3.1 | 18.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
3.1 | 21.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
3.1 | 50.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
3.1 | 6.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
3.1 | 9.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
3.1 | 3.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
3.1 | 34.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
3.1 | 31.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
3.1 | 3.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
3.1 | 55.7 | GO:0043531 | ADP binding(GO:0043531) |
3.0 | 325.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
3.0 | 145.8 | GO:0035326 | enhancer binding(GO:0035326) |
3.0 | 15.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
3.0 | 198.8 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
3.0 | 59.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
3.0 | 3.0 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
3.0 | 26.8 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
3.0 | 8.9 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
3.0 | 3.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
2.9 | 26.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.9 | 11.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.9 | 17.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
2.9 | 20.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
2.9 | 25.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
2.9 | 14.4 | GO:0008199 | ferric iron binding(GO:0008199) |
2.9 | 11.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.9 | 74.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
2.8 | 11.4 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
2.8 | 11.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
2.8 | 8.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
2.8 | 11.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.8 | 5.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.8 | 8.3 | GO:0048156 | tau protein binding(GO:0048156) |
2.8 | 2.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
2.8 | 11.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
2.8 | 5.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.7 | 24.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
2.7 | 10.9 | GO:0043842 | Kdo transferase activity(GO:0043842) |
2.7 | 13.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.7 | 8.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
2.7 | 2.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
2.7 | 91.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
2.7 | 8.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
2.7 | 13.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
2.7 | 29.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
2.7 | 10.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
2.7 | 24.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.7 | 10.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
2.6 | 5.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
2.6 | 15.8 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
2.6 | 5.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
2.6 | 128.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
2.6 | 34.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
2.6 | 7.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.6 | 10.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
2.6 | 2.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.6 | 5.2 | GO:0034452 | dynactin binding(GO:0034452) |
2.6 | 2.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.6 | 18.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
2.6 | 10.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
2.6 | 12.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
2.6 | 133.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
2.5 | 25.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.5 | 7.6 | GO:0055100 | adiponectin binding(GO:0055100) |
2.5 | 25.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.5 | 20.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
2.5 | 12.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.5 | 22.6 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
2.5 | 70.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
2.5 | 7.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
2.5 | 7.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.5 | 10.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
2.5 | 39.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
2.5 | 7.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
2.5 | 5.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
2.5 | 19.8 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
2.5 | 12.4 | GO:0050700 | CARD domain binding(GO:0050700) |
2.5 | 27.2 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
2.4 | 24.5 | GO:0070888 | E-box binding(GO:0070888) |
2.4 | 7.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
2.4 | 9.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.4 | 38.7 | GO:0001848 | complement binding(GO:0001848) |
2.4 | 33.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
2.4 | 31.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
2.4 | 21.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.4 | 21.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
2.4 | 28.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
2.4 | 16.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.4 | 2.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.3 | 18.8 | GO:0030515 | snoRNA binding(GO:0030515) |
2.3 | 32.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
2.3 | 21.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
2.3 | 7.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
2.3 | 48.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
2.3 | 4.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
2.3 | 6.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.3 | 55.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
2.3 | 29.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
2.3 | 34.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
2.3 | 9.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
2.3 | 4.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.3 | 13.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
2.2 | 6.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
2.2 | 11.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
2.2 | 42.2 | GO:0045502 | dynein binding(GO:0045502) |
2.2 | 55.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
2.2 | 6.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
2.2 | 6.6 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
2.2 | 23.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
2.2 | 12.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.1 | 6.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
2.1 | 6.3 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.1 | 8.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.1 | 215.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
2.1 | 8.4 | GO:0042731 | PH domain binding(GO:0042731) |
2.1 | 103.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
2.1 | 19.0 | GO:0039706 | co-receptor binding(GO:0039706) |
2.1 | 4.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.1 | 10.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
2.1 | 18.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.1 | 14.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
2.1 | 164.9 | GO:0051015 | actin filament binding(GO:0051015) |
2.1 | 2.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
2.1 | 26.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
2.0 | 4.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.0 | 4.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
2.0 | 4.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
2.0 | 4.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
2.0 | 6.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.0 | 8.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
2.0 | 195.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
2.0 | 8.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
2.0 | 6.0 | GO:0038132 | neuregulin binding(GO:0038132) |
2.0 | 56.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
2.0 | 4.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.0 | 20.0 | GO:0001618 | virus receptor activity(GO:0001618) |
2.0 | 14.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
2.0 | 8.0 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
2.0 | 9.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.0 | 3.9 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
2.0 | 132.1 | GO:0002020 | protease binding(GO:0002020) |
2.0 | 9.8 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.0 | 5.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
2.0 | 33.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
2.0 | 2.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.0 | 15.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
2.0 | 3.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.9 | 3.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.9 | 11.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.9 | 1.9 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.9 | 1.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.9 | 40.3 | GO:0030507 | spectrin binding(GO:0030507) |
1.9 | 1.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.9 | 15.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.9 | 15.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
1.9 | 1.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.9 | 17.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.9 | 5.6 | GO:0043515 | kinetochore binding(GO:0043515) |
1.9 | 18.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.9 | 9.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.8 | 1.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.8 | 22.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.8 | 1.8 | GO:0070538 | oleic acid binding(GO:0070538) |
1.8 | 7.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.8 | 40.2 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
1.8 | 124.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
1.8 | 5.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.8 | 5.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.8 | 5.4 | GO:0038100 | nodal binding(GO:0038100) |
1.8 | 5.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.8 | 12.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.8 | 7.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.8 | 37.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.8 | 5.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
1.8 | 16.0 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
1.8 | 10.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.8 | 62.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
1.8 | 5.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.8 | 3.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.8 | 8.8 | GO:0005113 | patched binding(GO:0005113) |
1.8 | 51.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.8 | 24.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.7 | 5.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.7 | 1.7 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.7 | 5.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.7 | 5.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.7 | 13.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.7 | 8.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
1.7 | 217.9 | GO:0008134 | transcription factor binding(GO:0008134) |
1.7 | 35.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.7 | 79.6 | GO:0001047 | core promoter binding(GO:0001047) |
1.7 | 23.6 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
1.7 | 5.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.7 | 5.0 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.7 | 18.4 | GO:0043621 | protein self-association(GO:0043621) |
1.7 | 3.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.7 | 9.9 | GO:0031419 | cobalamin binding(GO:0031419) |
1.7 | 11.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.7 | 1.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.6 | 4.9 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.6 | 64.6 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
1.6 | 20.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.6 | 4.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.6 | 4.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.6 | 1028.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
1.6 | 134.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.6 | 3.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.6 | 4.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.6 | 3.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.6 | 9.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.6 | 48.7 | GO:0017022 | myosin binding(GO:0017022) |
1.6 | 31.3 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
1.6 | 6.3 | GO:0048038 | quinone binding(GO:0048038) |
1.6 | 6.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.5 | 4.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.5 | 3.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.5 | 10.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.5 | 12.2 | GO:0043022 | ribosome binding(GO:0043022) |
1.5 | 30.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.5 | 9.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.5 | 9.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.5 | 6.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.5 | 4.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.5 | 1.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.5 | 5.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
1.5 | 2.9 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
1.5 | 16.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.5 | 1.5 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
1.5 | 8.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.5 | 2.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.4 | 2.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.4 | 20.1 | GO:0043236 | laminin binding(GO:0043236) |
1.4 | 14.2 | GO:0004568 | chitinase activity(GO:0004568) |
1.4 | 12.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.4 | 4.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.4 | 2.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.4 | 7.1 | GO:0017040 | ceramidase activity(GO:0017040) |
1.4 | 2.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.4 | 7.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.4 | 1.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.4 | 4.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.4 | 4.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.4 | 2.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.4 | 9.5 | GO:0038191 | neuropilin binding(GO:0038191) |
1.4 | 15.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.4 | 2.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.4 | 5.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.3 | 4.0 | GO:0032183 | SUMO binding(GO:0032183) |
1.3 | 6.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.3 | 13.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.3 | 8.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.3 | 27.9 | GO:0051020 | GTPase binding(GO:0051020) |
1.3 | 5.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
1.3 | 88.4 | GO:0005178 | integrin binding(GO:0005178) |
1.3 | 18.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.3 | 10.3 | GO:0032451 | demethylase activity(GO:0032451) |
1.3 | 3.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.3 | 10.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
1.3 | 2.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.3 | 28.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
1.3 | 2.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.3 | 5.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.3 | 3.8 | GO:0071253 | connexin binding(GO:0071253) |
1.3 | 15.2 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
1.3 | 8.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.3 | 8.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.3 | 3.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.2 | 3.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.2 | 1.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
1.2 | 1.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.2 | 27.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
1.2 | 2.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.2 | 3.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.2 | 4.9 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
1.2 | 4.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.2 | 2.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.2 | 14.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.2 | 106.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.2 | 1.2 | GO:0030371 | translation repressor activity(GO:0030371) |
1.2 | 15.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.2 | 5.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.2 | 41.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
1.2 | 9.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.2 | 3.5 | GO:0019808 | polyamine binding(GO:0019808) |
1.2 | 27.0 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
1.2 | 3.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.2 | 2.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
1.2 | 2.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.2 | 4.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
1.2 | 19.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.1 | 2.3 | GO:0060229 | lipase activator activity(GO:0060229) |
1.1 | 33.8 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.1 | 22.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.1 | 7.8 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.1 | 11.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.1 | 47.7 | GO:0019207 | kinase regulator activity(GO:0019207) |
1.1 | 7.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.1 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.1 | 2.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.1 | 5.4 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
1.1 | 2.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.1 | 9.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
1.1 | 3.2 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.1 | 15.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
1.1 | 2.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.1 | 14.0 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.1 | 19.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.1 | 4.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.1 | 5.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.1 | 7.5 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
1.1 | 10.5 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
1.0 | 5.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.0 | 1.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.0 | 31.2 | GO:0019003 | GDP binding(GO:0019003) |
1.0 | 4.1 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
1.0 | 25.9 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
1.0 | 2.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.0 | 3.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.0 | 6.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.0 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.0 | 5.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.0 | 15.1 | GO:0000049 | tRNA binding(GO:0000049) |
1.0 | 1.0 | GO:0004386 | helicase activity(GO:0004386) |
1.0 | 6.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 10.0 | GO:0019239 | deaminase activity(GO:0019239) |
1.0 | 4.0 | GO:0016208 | AMP binding(GO:0016208) |
1.0 | 81.7 | GO:0000287 | magnesium ion binding(GO:0000287) |
1.0 | 3.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.0 | 10.7 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
1.0 | 1.0 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
1.0 | 12.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.0 | 6.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.0 | 1.9 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.0 | 38.1 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
1.0 | 14.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
1.0 | 7.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.9 | 87.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.9 | 13.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.9 | 6.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.9 | 22.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.9 | 66.5 | GO:0003774 | motor activity(GO:0003774) |
0.9 | 4.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.9 | 30.7 | GO:0016887 | ATPase activity(GO:0016887) |
0.9 | 1.9 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.9 | 37.8 | GO:0008565 | protein transporter activity(GO:0008565) |
0.9 | 1.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.9 | 6.4 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.9 | 0.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.9 | 3.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.9 | 44.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.9 | 26.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.9 | 3.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.9 | 0.9 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.9 | 22.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.9 | 16.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.9 | 7.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.9 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.9 | 3.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.9 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.9 | 24.3 | GO:0004519 | endonuclease activity(GO:0004519) |
0.9 | 727.9 | GO:0003677 | DNA binding(GO:0003677) |
0.9 | 2.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.9 | 3.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.9 | 2.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.9 | 1.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 1.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.8 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.8 | 4.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.8 | 0.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.8 | 12.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.8 | 2.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.8 | 7.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 4.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 7.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.8 | 5.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.8 | 2.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.8 | 2.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.8 | 1.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.8 | 3.8 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.7 | 1.5 | GO:0019862 | IgA binding(GO:0019862) |
0.7 | 3.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.7 | 1.5 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.7 | 0.7 | GO:2001070 | starch binding(GO:2001070) |
0.7 | 2.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.7 | 14.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.7 | 67.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.7 | 2.1 | GO:0031432 | titin binding(GO:0031432) |
0.7 | 6.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.7 | 2.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.7 | 0.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.7 | 4.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 7.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.7 | 3.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 108.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.7 | 30.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.7 | 2.7 | GO:0005536 | glucose binding(GO:0005536) |
0.7 | 4.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 2.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 3.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 0.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.6 | 3.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.6 | 1.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.6 | 4.4 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.6 | 4.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.6 | 1.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.6 | 1.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.6 | 11.7 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.6 | 4.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.6 | 16.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.6 | 3.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.6 | 6.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 2.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.6 | 10.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.6 | 1.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.6 | 0.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 10.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.6 | 1.1 | GO:0034811 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.6 | 6.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.5 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.5 | 2.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.5 | 1.6 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 2.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 55.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 2.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.5 | 0.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.5 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 1.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.5 | 17.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.5 | 80.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.5 | 1.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.5 | 0.5 | GO:0001846 | opsonin binding(GO:0001846) |
0.5 | 1.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 0.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 40.8 | GO:0003723 | RNA binding(GO:0003723) |
0.4 | 4.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.4 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 1.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 71.7 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 1.2 | GO:0050543 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.4 | 0.8 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.4 | 8.3 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.4 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.4 | 1.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 1.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 8.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.4 | 9.1 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 43.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.3 | 6.8 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.3 | 3.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 3.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 3.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 9.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.3 | 2.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.3 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.3 | 4.9 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.3 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.3 | 2.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.3 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 1.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 1.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 3.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 2.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 1.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 2.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 6.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 38.4 | GO:0008270 | zinc ion binding(GO:0008270) |
0.2 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 1.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 3.4 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.2 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.6 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 2.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 5.9 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 1.0 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 1.4 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 1.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 5.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 13.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 12.3 | PID MYC PATHWAY | C-MYC pathway |
10.0 | 170.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
9.3 | 93.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
9.1 | 127.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
8.2 | 114.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
8.1 | 202.6 | PID IGF1 PATHWAY | IGF1 pathway |
8.0 | 224.1 | PID IFNG PATHWAY | IFN-gamma pathway |
8.0 | 55.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
7.5 | 366.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
7.4 | 185.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
7.3 | 160.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
7.2 | 79.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
6.9 | 13.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
6.6 | 6.6 | ST STAT3 PATHWAY | STAT3 Pathway |
6.6 | 32.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
6.5 | 148.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
6.2 | 161.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
6.0 | 54.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
6.0 | 48.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
5.9 | 171.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
5.9 | 93.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
5.7 | 57.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
5.5 | 192.7 | PID P53 REGULATION PATHWAY | p53 pathway |
5.5 | 60.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
5.2 | 114.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
5.2 | 57.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
5.1 | 66.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
5.0 | 110.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
4.9 | 157.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
4.8 | 178.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
4.8 | 161.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
4.6 | 36.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
4.2 | 4.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
4.2 | 8.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
4.2 | 142.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
4.1 | 124.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
4.1 | 49.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
4.1 | 53.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
4.1 | 121.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
4.0 | 52.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
4.0 | 118.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
3.9 | 27.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
3.9 | 11.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
3.8 | 41.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
3.8 | 11.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
3.7 | 102.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
3.6 | 29.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
3.6 | 71.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
3.6 | 124.6 | PID E2F PATHWAY | E2F transcription factor network |
3.5 | 99.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
3.5 | 59.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
3.4 | 37.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
3.4 | 44.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
3.3 | 46.7 | PID BARD1 PATHWAY | BARD1 signaling events |
3.2 | 105.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
3.2 | 60.2 | PID ARF6 PATHWAY | Arf6 signaling events |
3.1 | 91.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
3.1 | 12.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
3.0 | 117.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
3.0 | 8.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
3.0 | 23.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
3.0 | 121.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
2.9 | 49.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
2.9 | 81.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
2.8 | 39.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
2.7 | 71.4 | PID P73PATHWAY | p73 transcription factor network |
2.7 | 37.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
2.7 | 95.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
2.6 | 75.8 | PID PLK1 PATHWAY | PLK1 signaling events |
2.6 | 44.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
2.6 | 48.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
2.6 | 10.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
2.6 | 79.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
2.6 | 17.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
2.5 | 32.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
2.4 | 63.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
2.4 | 29.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
2.4 | 52.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
2.3 | 23.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
2.3 | 16.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
2.3 | 4.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.3 | 40.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
2.2 | 18.0 | PID BCR 5PATHWAY | BCR signaling pathway |
2.2 | 6.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.2 | 4.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
2.2 | 109.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
2.2 | 28.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.2 | 10.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
2.2 | 21.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
2.1 | 21.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
2.1 | 2.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.1 | 42.0 | PID AURORA B PATHWAY | Aurora B signaling |
2.1 | 2.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
2.0 | 26.4 | PID ATR PATHWAY | ATR signaling pathway |
2.0 | 16.2 | PID ATM PATHWAY | ATM pathway |
1.9 | 13.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.9 | 3.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.9 | 11.3 | PID ALK1 PATHWAY | ALK1 signaling events |
1.9 | 11.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.9 | 5.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.8 | 14.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.8 | 50.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
1.8 | 16.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.8 | 39.3 | PID NOTCH PATHWAY | Notch signaling pathway |
1.8 | 14.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.8 | 8.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.7 | 17.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.7 | 6.7 | PID FOXO PATHWAY | FoxO family signaling |
1.6 | 17.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.5 | 1.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.5 | 14.5 | PID ARF 3PATHWAY | Arf1 pathway |
1.4 | 1.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.4 | 9.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.4 | 17.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
1.4 | 17.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.3 | 1.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.3 | 5.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.3 | 10.0 | PID RHOA PATHWAY | RhoA signaling pathway |
1.2 | 9.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.2 | 18.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.1 | 4.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.1 | 5.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 17.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.0 | 17.8 | PID LKB1 PATHWAY | LKB1 signaling events |
1.0 | 12.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.0 | 2.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.0 | 3.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.0 | 14.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.0 | 15.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.9 | 3.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.9 | 14.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.9 | 1.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 13.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 10.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.7 | 7.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.7 | 0.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.7 | 2.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.7 | 7.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.7 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 19.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 3.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 14.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 4.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 4.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 2.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.5 | 1.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.5 | 4.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 6.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 0.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 2.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 0.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 36.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 2.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 12.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.8 | 109.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
17.0 | 17.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
13.5 | 121.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
11.9 | 106.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
11.6 | 69.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
11.3 | 214.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
11.2 | 22.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
10.5 | 21.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
10.0 | 10.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
9.2 | 202.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
9.2 | 73.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
9.0 | 143.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
8.7 | 8.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
7.5 | 120.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
7.2 | 172.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
7.1 | 142.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
7.0 | 21.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
7.0 | 55.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
6.7 | 107.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
6.7 | 100.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
6.7 | 73.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
6.6 | 73.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
6.6 | 79.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
6.6 | 138.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
6.6 | 85.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
6.5 | 19.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
6.3 | 94.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
6.3 | 18.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
6.1 | 147.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
6.1 | 54.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
5.9 | 112.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
5.6 | 5.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
5.5 | 116.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
5.5 | 5.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
5.4 | 26.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
5.3 | 32.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
5.3 | 105.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
5.2 | 52.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
5.2 | 5.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
5.2 | 46.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
5.0 | 20.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
5.0 | 25.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
5.0 | 10.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
4.9 | 29.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
4.8 | 57.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
4.8 | 28.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
4.8 | 85.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
4.7 | 37.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
4.6 | 46.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
4.6 | 320.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
4.6 | 46.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
4.6 | 36.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
4.6 | 72.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
4.6 | 36.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
4.5 | 90.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
4.5 | 17.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
4.5 | 8.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
4.4 | 22.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
4.3 | 78.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
4.3 | 34.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
4.3 | 21.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
4.3 | 42.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
4.3 | 34.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
4.2 | 58.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
4.1 | 12.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
4.1 | 146.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
4.0 | 52.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
4.0 | 28.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
3.9 | 105.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
3.9 | 42.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
3.9 | 61.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
3.8 | 53.8 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
3.8 | 61.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
3.8 | 45.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.8 | 94.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
3.7 | 3.7 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
3.7 | 29.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
3.7 | 62.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
3.6 | 50.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.6 | 43.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
3.6 | 159.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
3.6 | 64.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
3.6 | 43.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
3.6 | 132.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
3.6 | 14.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
3.5 | 31.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
3.5 | 31.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
3.4 | 3.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
3.4 | 37.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
3.4 | 305.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
3.4 | 10.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
3.4 | 53.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
3.4 | 23.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
3.3 | 26.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
3.3 | 32.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
3.3 | 19.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
3.2 | 3.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
3.1 | 72.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
3.0 | 3.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
3.0 | 62.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
2.9 | 44.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
2.9 | 58.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
2.9 | 34.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.9 | 106.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
2.8 | 25.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.8 | 61.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
2.8 | 5.5 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
2.7 | 35.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.7 | 21.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
2.7 | 39.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
2.6 | 47.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.6 | 203.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
2.6 | 23.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
2.6 | 76.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.5 | 68.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
2.5 | 15.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
2.5 | 20.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
2.5 | 9.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
2.4 | 2.4 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
2.4 | 34.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
2.4 | 17.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
2.4 | 21.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.4 | 7.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.3 | 46.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
2.3 | 9.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
2.3 | 67.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
2.3 | 2.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
2.3 | 22.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
2.3 | 49.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.3 | 52.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
2.2 | 47.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
2.2 | 74.2 | REACTOME TRANSLATION | Genes involved in Translation |
2.2 | 123.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
2.2 | 26.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
2.2 | 15.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
2.2 | 32.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
2.2 | 24.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
2.2 | 21.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.2 | 23.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
2.2 | 15.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
2.2 | 19.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
2.1 | 184.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
2.1 | 22.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
2.0 | 6.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.0 | 22.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
2.0 | 4.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
2.0 | 3.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.9 | 3.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.9 | 30.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.9 | 19.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.9 | 13.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.9 | 1.9 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
1.9 | 22.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.8 | 18.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.8 | 12.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.8 | 38.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.8 | 14.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.8 | 54.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
1.8 | 9.0 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
1.8 | 278.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.8 | 12.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.8 | 19.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.7 | 19.2 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
1.7 | 27.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.7 | 36.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.7 | 72.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.6 | 36.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
1.6 | 19.4 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
1.5 | 26.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.5 | 23.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.5 | 4.6 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
1.5 | 13.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
1.5 | 13.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.5 | 22.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
1.4 | 23.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.4 | 7.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.4 | 12.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.4 | 25.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.4 | 16.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.4 | 33.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.3 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 2.6 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.3 | 21.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.2 | 20.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
1.2 | 15.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.2 | 4.7 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
1.2 | 13.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.2 | 20.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
1.1 | 15.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.1 | 7.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.1 | 7.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.1 | 18.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
1.1 | 8.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.1 | 4.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
1.1 | 28.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.0 | 4.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
1.0 | 30.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.0 | 21.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.0 | 5.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.0 | 15.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.0 | 5.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.9 | 5.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.9 | 20.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.8 | 4.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.8 | 0.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.8 | 45.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.8 | 3.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.7 | 24.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.7 | 26.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.7 | 1.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 5.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.7 | 14.8 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.7 | 5.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 26.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 3.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 12.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.6 | 7.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.6 | 1.8 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.6 | 2.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 3.5 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.6 | 1.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 4.9 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.5 | 3.0 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.5 | 0.5 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.5 | 10.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.4 | 18.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 6.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 7.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 3.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.4 | 4.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 32.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 17.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 1.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 2.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 6.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 0.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 1.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 3.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |